<SEC-DOCUMENT>0001193125-23-189608.txt : 20230719
<SEC-HEADER>0001193125-23-189608.hdr.sgml : 20230719
<ACCEPTANCE-DATETIME>20230719160100
ACCESSION NUMBER:		0001193125-23-189608
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230718
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230719
DATE AS OF CHANGE:		20230719

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NeuroPace Inc
		CENTRAL INDEX KEY:			0001528287
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				223550230
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40337
		FILM NUMBER:		231096691

	BUSINESS ADDRESS:	
		STREET 1:		455 N. BERNARDO AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		6502372700

	MAIL ADDRESS:	
		STREET 1:		455 N. BERNARDO AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d451420d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:npce="http://neuropace.com/20230718" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-07-18_to_2023-07-18">NeuroPace Inc</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-07-18_to_2023-07-18">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-07-18_to_2023-07-18">0001528287</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="npce-20230718.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-07-18_to_2023-07-18"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001528287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-18</xbrli:startDate> <xbrli:endDate>2023-07-18</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-07-18_to_2023-07-18">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-07-18_to_2023-07-18" format="ixt:datemonthdayyearen">July&#160;18, 2023</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">NEUROPACE, INC.</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-07-18_to_2023-07-18" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-07-18_to_2023-07-18">001-40337</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-07-18_to_2023-07-18">22-3550230</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:33%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:33%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-07-18_to_2023-07-18">455 N. Bernardo Avenue</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-07-18_to_2023-07-18">Mountain View</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-07-18_to_2023-07-18">CA</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-07-18_to_2023-07-18">94043</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-07-18_to_2023-07-18">(650)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-07-18_to_2023-07-18">237-2700</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="text-decoration:underline">see</span> General Instructions A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-07-18_to_2023-07-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-07-18_to_2023-07-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-07-18_to_2023-07-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-07-18_to_2023-07-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-07-18_to_2023-07-18">Common Stock, $0.001 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-07-18_to_2023-07-18">NPCE</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-07-18_to_2023-07-18" format="ixt-sec:exchnameen">Nasdaq Global Market</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-07-18_to_2023-07-18" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2023-07-18_to_2023-07-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;18, 2023, the Compensation Committee of the Board of Directors (the &#8220;Board&#8221;) of NeuroPace, Inc. approved the NeuroPace, Inc. 2023 Inducement Plan (the &#8220;Inducement Plan&#8221;). The terms of the Inducement Plan are substantially similar to the terms of NeuroPace&#8217;s 2021 Equity Incentive Plan with the exception that incentive stock options may not be issued under the Inducement Plan and awards under the Inducement Plan may only be issued to eligible recipients under the applicable Nasdaq rules. The Inducement Plan was adopted by the Compensation Committee without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NeuroPace has initially reserved 380,424 shares of NeuroPace&#8217;s common stock for issuance pursuant to awards granted under the Inducement Plan. In accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules, awards under the Inducement Plan may only be made to an employee who has not previously been an employee or member of the board of directors of NeuroPace or any subsidiary, or following a bona fide period of <span style="white-space:nowrap">non-employment</span> by NeuroPace or a subsidiary, if he or she is granted such award in connection with his or her commencement of employment with NeuroPace or a subsidiary and such grant is an inducement material to his or her entering into employment with NeuroPace or such subsidiary. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;18, 2023, the Compensation Committee granted an option to purchase 380,424 shares of NeuroPace&#8217;s common stock to Joel Becker as Chief Executive Officer pursuant to Mr.&#160;Becker&#8217;s offer letter described in NeuroPace&#8217;s Form <span style="white-space:nowrap">8-K</span> filed with the Securities and Exchange commission on June&#160;28, 2023, as a material inducement for Mr.&#160;Becker to join NeuroPace as its Chief Executive Officer. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Inducement Plan does not purport to be complete and is subject to, and qualified in its entirety by, the complete text of the Inducement Plan and the forms of award agreements adopted under the Plan, copies of which are filed as Exhibit 10.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and are incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br />No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d451420dex101.htm">NeuroPace, Inc. 2023 Inducement Plan, Form of Stock Option Grant Notice, and Form of Stock Option Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">NeuroPace, Inc.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Dated: July&#160;19, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Irina Ridley</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Irina Ridley</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Legal Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d451420dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N<SMALL>EURO</SMALL>P<SMALL>ACE</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2023 I<SMALL>NDUCEMENT</SMALL> P<SMALL>LAN</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>DOPTED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPENSATION</SMALL> C<SMALL>OMMITTEE</SMALL> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL>: J<SMALL>ULY</SMALL>&nbsp;18, 2023
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. G<SMALL>ENERAL</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a) </B><B>E</B><B>ligible Award Recipients.</B> The only persons eligible to receive grants of Stock Awards under this Plan are
individuals who satisfy the standards for inducement grants under Nasdaq Marketplace Rule 5635(c)(4) or 5635(c)(3), if applicable, and the related guidance under Nasdaq IM <FONT STYLE="white-space:nowrap">5635-1.</FONT> A person who previously
served as an Employee or Director will not be eligible to receive Stock Awards under the Plan, other than following a <I>bona fide</I> period of <FONT STYLE="white-space:nowrap">non-employment.</FONT> Persons eligible to receive grants of Stock
Awards under this Plan are referred to in this Plan as &#147;<B><I>Eligible Employees</I></B>.&#148; These Stock Awards must be approved by either a majority of the Company&#146;s &#147;Independent Directors&#148; (as such term is defined in Nasdaq
Marketplace Rule 5605(a)(2)) (&#147;<B><I>Independent Directors</I></B>&#148;) or the Company&#146;s compensation committee, provided such committee is comprised solely of Independent Directors of the Company (the &#147;<B><I>Independent
Compensation Committee</I></B>&#148;) in order to comply with the exemption from the stockholder approval requirement for &#147;inducement grants&#148; provided under Rule 5635(c)(4) of the Nasdaq Marketplace Rules. Nasdaq Marketplace Rule
5635(c)(4) and the related guidance under Nasdaq IM <FONT STYLE="white-space:nowrap">5635-1</FONT> (together with any analogous rules or guidance effective after the date hereof, the &#147;<B><I>Inducement Award Rules</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) </B><B>Available Stock Awards.</B> The Plan provides for the grant of the following Stock Awards: (i)&nbsp;Nonstatutory Stock Options,
(ii)&nbsp;Stock Appreciation Rights (iii)&nbsp;Restricted Stock Awards, (iv)&nbsp;Restricted Stock Unit Awards, (v)&nbsp;Performance Stock Awards, and (vi)&nbsp;Other Stock Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c) </B><B>Purpose.</B> The Company, by means of the Plan, intends to provide (i)&nbsp;an inducement material for certain individuals to
enter into employment with the Company within the meaning of Rule 5635(c)(4) of the Nasdaq Marketplace Rules, (ii)&nbsp;incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and (iii)&nbsp;a means by
which Eligible Employees may be given an opportunity to benefit from increases in value of the Common Stock through the granting of Stock Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2.
A<SMALL>DMINISTRATION</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Administration by Board.</B> The Board will administer the Plan; provided however, that Stock
Awards may only be granted by either (i)&nbsp;a majority of the Company&#146;s Independent Directors or (ii)&nbsp;the Independent Compensation Committee. Subject to those constraints and the other constraints of the Inducement Award Rules, the Board
may delegate some of its powers of administration of the Plan to a Committee or Committees, as provided in Section&nbsp;2(c). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)
Powers of Board.</B> The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan and the Inducement Award Rules: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i) </B>To determine: (A)&nbsp;who will be granted Stock Awards; (B)&nbsp;when and how each Stock Award will be granted; (C)&nbsp;what type
of Stock Award will be granted; (D)&nbsp;the provisions of each Stock Award (which need not be identical), including when a person will be permitted to exercise or otherwise receive cash or Common Stock under the Stock Award; (E)&nbsp;the number of
shares of Common Stock subject to, or the cash value of, a Stock Award; and (F)&nbsp;the Fair Market Value applicable to a Stock Award, provided, however, that Stock Awards may only be granted by either (i)&nbsp;a majority of the Company&#146;s
Independent Directors or (ii)&nbsp;the Independent Compensation Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii) </B>To construe and interpret the Plan and Stock Awards granted under it, and to
establish, amend and revoke rules and regulations for administration of the Plan and Stock Awards. The Board, in the exercise of these powers, may correct any defect, omission or inconsistency in the Plan or in any Stock Award Agreement, in a manner
and to the extent it will deem necessary or expedient to make the Plan or Stock Award fully effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii) </B>To settle all
controversies regarding the Plan and Stock Awards granted under it. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iv) </B>To accelerate, in whole or in part, the time at which a
Stock Award may be exercised or vest (or the time at which cash or shares of Common Stock may be issued in settlement thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(v)
</B>To suspend or terminate the Plan at any time. Except as otherwise provided in the Plan or a Stock Award Agreement, suspension or termination of the Plan will not impair a Participant&#146;s rights under the Participant&#146;s then-outstanding
Stock Award without the Participant&#146;s written consent, except as provided in subsection (viii)&nbsp;below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(vi) </B>To amend the
Plan in any respect the Board deems necessary or advisable; provided, however, that stockholder approval will be required for any amendment to the extent required by Applicable Law. Except as provided in the Plan (including subsection
(viii)&nbsp;below) or a Stock Award Agreement, no amendment of the Plan will impair a Participant&#146;s rights under an outstanding Stock Award unless (1)&nbsp;the Company requests the consent of the affected Participant, and (2)&nbsp;such
Participant consents in writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(vii) </B>To submit any amendment to the Plan for stockholder approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(viii) </B>To approve forms of Stock Award Agreements for use under the Plan and to amend the terms of any one or more Stock Awards,
including, but not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Stock Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion; <I>provided,
however,</I> that a Participant&#146;s rights under any Stock Award will not be impaired by any such amendment unless (A)&nbsp;the Company requests the consent of the affected Participant, and (B)&nbsp;such Participant consents in writing.
Notwithstanding the foregoing, (1)&nbsp;a Participant&#146;s rights will not be deemed to have been impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially impair the
Participant&#146;s rights, and (2)&nbsp;subject to the limitations of applicable law, if any, the Board may amend the terms of any one or more Stock Awards without the affected Participant&#146;s consent (A)&nbsp;to clarify the manner of exemption
from, or to bring the Stock Award into compliance with, Section&nbsp;409A of the Code or (B)&nbsp;to comply with other applicable laws or listing requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ix) </B>Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best
interests of the Company and that are not in conflict with the provisions of the Plan or Stock Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(x) </B>To adopt such rules,
procedures and <FONT STYLE="white-space:nowrap">sub-plans</FONT> related to the operation and administration of the Plan as are necessary or appropriate under local laws and regulations to permit participation in the Plan by Eligible Employees who
are foreign nationals or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Stock Award Agreement made to ensure or facilitate compliance with the laws or
regulations of the relevant foreign jurisdiction). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c) Delegation to Committee. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i) </B><B>General.</B> Subject to the terms of Section&nbsp;2(b), the Board may delegate some or all of the administration of the Plan to
a Committee or Committees. If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the
Committee, including the power to delegate to a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee, as
applicable). Any delegation of administrative powers will be reflected in resolutions, not inconsistent with the provisions of the Plan, adopted from time to time by the Board or Committee (as applicable). The Board may retain the authority to
concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously delegated. Whether or not the Board has delegated administration of the Plan to a Committee, the Board will have the
final power to determine all questions of policy and expediency that may arise in the administration of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii) </B><B>Rule <FONT
STYLE="white-space:nowrap">16b-3</FONT> Compliance.</B> The Committee may consist solely of two or more <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors, in accordance with Rule <FONT STYLE="white-space:nowrap">16b-3.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d) </B><B>Effect of Board</B><B>&#146;</B><B>s Decision.</B> All determinations, interpretations and constructions made by the Board in
good faith will not be subject to review by any person and will be final, binding and conclusive on all persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e) Cancellation and <FONT
STYLE="white-space:nowrap">Re-Grant</FONT> of Stock Awards. </B>Neither the Board nor any Committee will have the authority to (i)&nbsp;reduce the exercise price or strike price of any outstanding Options or Stock Appreciation Rights under the Plan,
or (ii)&nbsp;cancel any outstanding Options or Stock Appreciation Rights that have an exercise price or strike price greater than the current Fair Market Value of the Common Stock in exchange for cash or other Stock Awards under the Plan, unless the
stockholders of the Company have approved such an action within twelve months prior to such an event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. S<SMALL>HARES</SMALL> S<SMALL>UBJECT</SMALL>
<SMALL>TO</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Share Reserve. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i) </B>Subject to Section&nbsp;9(a) relating to Capitalization Adjustments, the aggregate number of shares of Common Stock that may be
issued pursuant to Stock Awards will not exceed 380,424 shares (the &#147;<B><I>Share Reserve</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i) </B>For clarity, the
Share Reserve in this Section&nbsp;3(a) is a limitation on the number of shares of Common Stock that may be issued pursuant to the Plan. As a single share may be subject to grant more than once (e.g., if a share subject to a Stock Award is
forfeited, it may be made subject to grant again as provided in Section&nbsp;3(b) below), the Share Reserve is not a limit on the number of Stock Awards that can be granted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii) </B>Shares may be issued in connection with a merger or acquisition as permitted by Nasdaq Listing Rule 5635(c) or, if applicable,
NYSE Listed Company Manual Section&nbsp;303A.08, NYSE American Company Guide Section&nbsp;711 or other applicable rule, and such issuance will not reduce the number of shares available for issuance under the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Reversion of Shares to the Share Reserve. </B>If a Stock Award or any portion thereof
(i)&nbsp;expires or otherwise terminates without all of the shares covered by such Stock Award having been issued or (ii)&nbsp;is settled in cash (<I>i.e.</I>, the Participant receives cash rather than stock), such expiration, termination or
settlement will not reduce (or otherwise offset) the number of shares of Common Stock that may be available for issuance under the Plan. If any shares of Common Stock issued pursuant to a Stock Award are forfeited back to or repurchased by the
Company because of the failure to meet a contingency or condition required to vest such shares in the Participant, then the shares that are forfeited, repurchased or so surrendered will again become available for issuance under the Plan. Any shares
reacquired by the Company in satisfaction of tax withholding obligations on a Stock Award or as consideration for the exercise or purchase price of a Stock Award will again become available for issuance under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c) Source of Shares.</B> The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including
shares repurchased by the Company on the open market or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. E<SMALL>LIGIBILITY</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a) </B><B>Eligible Award Recipients</B>. Stock Awards may only be granted to persons who are Eligible Employees described in
Section&nbsp;1(a) of the Plan, where the Award is an inducement material to the individual&#146;s entering into employment with the Company or an Affiliate within the meaning of Rule 5635(c)(4) of the Nasdaq Marketplace Rules or is otherwise
permitted pursuant to Rule 5635(c) of the Nasdaq Marketplace Rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Eligibility for Specific Stock Awards.</B> Nonstatutory Stock
Options and SARs may not be granted to Eligible Employees who are providing Continuous Service only to any &#147;parent&#148; of the Company, as such term is defined in Rule 405 of the Securities Act, unless (i)&nbsp;the stock underlying such Stock
Awards is treated as &#147;service recipient stock&#148; under Section&nbsp;409A of the Code (for example, because the Stock Awards are granted pursuant to a corporate transaction such as a spin off transaction), (ii) the Company, in consultation
with its legal counsel, has determined that such Stock Awards are otherwise exempt from Section&nbsp;409A of the Code, or (iii)&nbsp;the Company, in consultation with its legal counsel, has determined that such Stock Awards comply with the
requirements of Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c) Approval Requirements. </B>All Awards must be granted either by a majority of the
Company&#146;s Independent Directors or the Independent Compensation Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. P<SMALL>ROVISIONS</SMALL> R<SMALL>ELATING</SMALL> <SMALL>TO</SMALL>
O<SMALL>PTIONS</SMALL> <SMALL>AND</SMALL> S<SMALL>TOCK</SMALL> A<SMALL>PPRECIATION</SMALL> R<SMALL>IGHTS</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Option or SAR
will be in such form and will contain such terms and conditions as the Board deems appropriate. All Options will be Nonstatutory Stock Options at the time of grant. The provisions of separate Options or SARs need not be identical; <I>provided,
however</I>, that each Stock Award Agreement will conform to (through incorporation of provisions hereof by reference in the applicable Stock Award Agreement or otherwise) the substance of each of the following provisions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Term.</B> No Option or SAR will be exercisable after the expiration of ten years from the date of its grant or such shorter period
specified in the Stock Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Exercise Price.</B> The exercise or strike price of each Option or SAR will be not less
than 100% of the Fair Market Value of the Common Stock subject to the Option or SAR on the date the Stock Award is granted. Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than 100% of the Fair
Market Value of the Common Stock subject to the Stock Award if such Stock Award is granted pursuant to an assumption of or substitution for another option or stock appreciation right pursuant to a Corporate Transaction and in a manner consistent
with the provisions of Section&nbsp;409A of the Code . Each SAR will be denominated in shares of Common Stock equivalents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c) Purchase Price for Options.</B> The purchase price of Common Stock acquired pursuant
to the exercise of an Option may be paid, to the extent permitted by applicable law and as determined by the Board in its sole discretion, by any combination of the methods of payment set forth below. The Board will have the authority to grant
Options that do not permit all of the following methods of payment (or otherwise restrict the ability to use certain methods) and to grant Options that require the consent of the Company to use a particular method of payment. The permitted methods
of payment are as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i) </B>by cash, check, bank draft or money order payable to the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii) </B>pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of the
stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii) </B>by a &#147;net exercise&#148; arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable
upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price; <I>provided, however</I>, that the Company will accept a cash or other payment from the Participant to the extent of any
remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole shares to be issued. Shares of Common Stock will no longer be subject to an Option and will not be exercisable thereafter to the extent that
(A)&nbsp;shares issuable upon exercise are used to pay the exercise price pursuant to the &#147;net exercise,&#148; (B) shares are delivered to the Participant as a result of such exercise, and/or (C)&nbsp;shares are withheld to satisfy tax
withholding obligations; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iv) </B>in any other form of legal consideration that may be acceptable to the Board and specified in the
applicable Stock Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d) </B><B>Exercise and Payment of a SAR.</B> To exercise any outstanding SAR, the Participant must
provide written notice of exercise to the Company in compliance with the provisions of the Stock Appreciation Right Agreement evidencing such SAR. The appreciation distribution payable on the exercise of a SAR will be not greater than an amount
equal to the excess of (A)&nbsp;the aggregate Fair Market Value (on the date of the exercise of the SAR) of a number of shares of Common Stock equal to the number of Common Stock equivalents in which the Participant is vested under such SAR, and
with respect to which the Participant is exercising the SAR on such date, over (B)&nbsp;the aggregate strike price of the number of Common Stock equivalents with respect to which the Participant is exercising the SAR on such date. The appreciation
distribution may be paid in Common Stock, in cash, in any combination of the two or in any other form of consideration, as determined by the Board and contained in the Stock Award Agreement evidencing such SAR. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e) Transferability of Options and SARs.</B> The Board may, in its sole discretion, impose such limitations on the transferability of
Options and SARs as the Board will determine. In the absence of such a determination by the Board to the contrary, the following restrictions on the transferability of Options and SARs will apply: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i) Restrictions on Transfer.</B> An Option or SAR will not be transferable except by will or by the laws of descent and distribution (or
pursuant to subsections (ii)&nbsp;and (iii) below), and will be exercisable during the lifetime of the Participant only by the Participant. The Board may permit transfer of the Option or SAR in a manner that is not prohibited by applicable laws or
regulations. Except as explicitly provided in the Plan, neither an Option nor a SAR may be transferred for consideration. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii) Domestic Relations Orders.</B> Subject to the approval of the Board or a duly
authorized Officer, an Option or SAR may be transferred pursuant to the terms of a domestic relations order, official marital settlement agreement or other official divorce or separation instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii) Beneficiary Designation.</B> Subject to the approval of the Board or a duly authorized Officer, a Participant may, by delivering
written notice to the Company or to any third party designated by the Company, in a form approved by the Company (or the designated broker), designate a third party who, upon the death of the Participant, will thereafter be entitled to exercise the
Option or SAR and receive the Common Stock or other consideration resulting from such exercise. In the absence of such a designation, upon the death of the Participant, the executor or administrator of the Participant&#146;s estate or the
Participant&#146;s legal heirs will be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from such exercise. However, the Company may prohibit designation of a beneficiary at any time, including due
to any conclusion by the Company that such designation would be inconsistent with the provisions of applicable laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f) Vesting
Generally.</B> The total number of shares of Common Stock subject to an Option or SAR may vest and become exercisable in periodic installments that may or may not be equal. The Option or SAR may be subject to such other terms and conditions on the
time or times when it may or may not be exercised (which may be based on the satisfaction of Performance Goals or other criteria) as the Board may deem appropriate. The vesting provisions of individual Options or SARs may vary. The provisions of
this Section&nbsp;5(f) are subject to any Option or SAR provisions governing the minimum number of shares of Common Stock as to which an Option or SAR may be exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g) </B><B>Termination of Continuous Service.</B> Except as otherwise provided in the applicable Stock Award Agreement or other agreement
between the Participant and the Company, if a Participant&#146;s Continuous Service terminates (other than for Cause and other than upon the Participant&#146;s death or Disability), the Participant may exercise his or her Option or SAR (to the
extent that the Participant was entitled to exercise such Stock Award as of the date of termination of Continuous Service) within the period of time ending on the earlier of (i)&nbsp;the date which occurs three (3)&nbsp;months following the
termination of the Participant&#146;s Continuous Service (or such longer or shorter period specified in the applicable Stock Award Agreement), and (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the Stock Award Agreement.
If, after termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time frame, the Option or SAR will terminate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(h) </B><B>Extension of Termination Date.</B> Except as otherwise provided in the applicable Stock Award Agreement or other agreement
between the Participant and the Company, if the exercise of an Option or SAR following the termination of the Participant&#146;s Continuous Service would be prohibited at any time solely because the issuance of shares of Common Stock would violate
the registration requirements under the Securities Act, then the Option or SAR will terminate on the earlier of (i)&nbsp;the expiration of a total period of time (that need not be consecutive) equal to the applicable post termination exercise period
after the termination of the Participant&#146;s Continuous Service during which the exercise of the Option or SAR would not be in violation of such registration requirements, and (ii)&nbsp;the expiration of the term of the Option or SAR as set forth
in the applicable Stock Award Agreement. In addition, unless otherwise provided in a Participant&#146;s Stock Award Agreement, if the sale of any Common Stock received upon exercise of an Option or SAR following the termination of the
Participant&#146;s Continuous Service would violate the Company&#146;s insider trading policy, then the Option or SAR will terminate on the earlier of (i)&nbsp;the expiration of the period of months (that need not be consecutive) equal to the
applicable post- termination exercise period after the termination of the Participant&#146;s Continuous Service during which the sale of the Common Stock received upon exercise of the Option or SAR would not be in violation of the Company&#146;s
insider trading policy, or (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the applicable Stock Award Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(i) </B><B>Disability of Participant.</B> Except as otherwise provided in the applicable
Stock Award Agreement or other agreement between the Participant and the Company, if a Participant&#146;s Continuous Service terminates as a result of the Participant&#146;s Disability, the Participant may exercise his or her Option or SAR (to the
extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i)&nbsp;the date which occurs 12 months following such
termination of Continuous Service (or such longer or shorter period specified in the Stock Award Agreement), and (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the Stock Award Agreement. If, after termination of Continuous
Service, the Participant does not exercise his or her Option or SAR within the applicable time frame, the Option or SAR (as applicable) will terminate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(j) </B><B>Death of Participant.</B> Except as otherwise provided in the applicable Stock Award Agreement or other agreement between the
Participant and the Company, if (i)&nbsp;a Participant&#146;s Continuous Service terminates as a result of the Participant&#146;s death, or (ii)&nbsp;the Participant dies within the period (if any) specified in the Stock Award Agreement for
exercisability after the termination of the Participant&#146;s Continuous Service for a reason other than death, then the Option or SAR may be exercised (to the extent the Participant was entitled to exercise such Option or SAR as of the date of
death) by the Participant&#146;s estate, by a person who acquired the right to exercise the Option or SAR by bequest or inheritance or by a person designated to exercise the Option or SAR upon the Participant&#146;s death, but only within the period
ending on the earlier of (i)&nbsp;the date 18 months following the date of death (or such longer or shorter period specified in the Stock Award Agreement), and (ii)&nbsp;the expiration of the term of such Option or SAR as set forth in the Stock
Award Agreement. If, after the Participant&#146;s death, the Option or SAR is not exercised within the applicable time frame, the Option or SAR (as applicable) will terminate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(k) </B><B>Termination for Cause.</B> Except as explicitly provided otherwise in the applicable Stock Award Agreement or other written
agreement between the Participant and the Company, if a Participant&#146;s Continuous Service is terminated for Cause, the Option or SAR will terminate immediately upon such Participant&#146;s termination of Continuous Service, and the Participant
will be prohibited from exercising his or her Option or SAR from and after the date of such termination of Continuous Service. If a Participant&#146;s Continuous Service is suspended pending an investigation of the existence of Cause, all of the
Participant&#146;s rights under the Option or SAR will also be suspended during the investigation period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(l) <FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Employees</B>. If an Option or SAR is granted to an Employee who is a <FONT STYLE="white-space:nowrap">non-exempt</FONT> employee for purposes of the U.S. Fair Labor Standards Act of 1938, as amended, the
Option or SAR will not be first exercisable for any shares of Common Stock until at least six months following the date of grant of the Option or SAR (although the Stock Award may vest prior to such date). Consistent with the provisions of the U.S.
Worker Economic Opportunity Act, (i)&nbsp;if such <FONT STYLE="white-space:nowrap">non-exempt</FONT> Employee dies or suffers a Disability, (ii)&nbsp;upon a Corporate Transaction in which such Option or SAR is not assumed, continued, or substituted,
(iii)&nbsp;upon a Change in Control, or (iv)&nbsp;upon the Participant&#146;s retirement (as such term may be defined in the Participant&#146;s Stock Award Agreement in another agreement between the Participant and the Company, or, if no such
definition, in accordance with the Company&#146;s then current employment policies and guidelines), the vested portion of any Options and SARs may be exercised earlier than six months following the date of grant. The foregoing provision is intended
to operate so that any income derived by a <FONT STYLE="white-space:nowrap">non-exempt</FONT> employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay. To the extent permitted and/or
required for compliance with the U.S. Worker Economic Opportunity Act to ensure that any income derived by a non- exempt employee in connection with the exercise, vesting or issuance of any shares under any other Stock Award will be exempt from the
employee&#146;s regular rate of pay, the provisions of this Section&nbsp;5(l) will apply to all Stock Awards and are hereby incorporated by reference into such Stock Award Agreements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. P<SMALL>ROVISIONS</SMALL> <SMALL>OF</SMALL> S<SMALL>TOCK</SMALL> A<SMALL>WARDS</SMALL>
<SMALL>OTHER</SMALL> <SMALL>THAN</SMALL> O<SMALL>PTIONS</SMALL> <SMALL>AND</SMALL> SAR<SMALL>S</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Restricted Stock
Awards.</B> Each Restricted Stock Award Agreement will be in such form and will contain such terms and conditions as the Board will deem appropriate. To the extent consistent with the Company&#146;s bylaws, at the Board&#146;s election, shares of
Common Stock may be (x)&nbsp;held in book entry form subject to the Company&#146;s instructions until any restrictions relating to the Restricted Stock Award lapse; or (y)&nbsp;evidenced by a certificate, which certificate will be held in such form
and manner as determined by the Board. The terms and conditions of Restricted Stock Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Award Agreements need not be identical. Each Restricted
Stock Award Agreement will conform to (through incorporation of the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i) Consideration.</B> A Restricted Stock Award may be awarded in consideration for (A)&nbsp;cash, check, bank draft or money order payable
to the Company, or (B)&nbsp;any other form of legal consideration (including future services) that may be acceptable to the Board, in its sole discretion, and permissible under applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii) Vesting. </B>Shares of Common Stock awarded under the Restricted Stock Award Agreement may be subject to forfeiture to the Company in
accordance with a vesting schedule to be determined by the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii) Termination of Participant&#146;s Continuous Service.</B> If a
Participant&#146;s Continuous Service terminates, the Company may receive through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant that have not vested as of the date of termination of
Continuous Service under the terms of the Restricted Stock Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iv) Transferability.</B> Rights to acquire shares of
Common Stock under the Restricted Stock Award Agreement will be transferable by the Participant only upon such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board will determine in its sole discretion, so long
as Common Stock awarded under the Restricted Stock Award Agreement remains subject to the terms of the Restricted Stock Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(v) Dividends. </B>A Restricted Stock Award Agreement may provide that any dividends paid on Restricted Stock will be subject to the same
vesting and forfeiture restrictions as apply to the shares of Common Stock subject to the Restricted Stock Award to which they relate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) </B><B>Restricted Stock Unit Awards. </B>Each Restricted Stock Unit Award Agreement will be in such form and will contain such terms
and conditions as the Board will deem appropriate. The terms and conditions of Restricted Stock Unit Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Unit Award Agreements need not be
identical. Each Restricted Stock Unit Award Agreement will conform to (through incorporation of the provisions hereof by reference in the Agreement or otherwise) the substance of each of the following provisions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i) </B><B>Consideration.</B> At the time of grant of a Restricted Stock Unit Award, the Board will determine the consideration, if any, to
be paid by the Participant upon delivery of each share of Common Stock subject to the Restricted Stock Unit Award. The consideration to be paid (if any) by the Participant for each share of Common Stock subject to a Restricted Stock Unit Award may
be paid in any form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii) </B><B>Vesting. </B>At the time of the grant of a Restricted Stock Unit Award, the
Board may impose such restrictions on or conditions to the vesting of the Restricted Stock Unit Award as it, in its sole discretion, deems appropriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii) </B><B>Payment</B><B>.</B> A Restricted Stock Unit Award may be settled by the delivery of shares of Common Stock, their cash
equivalent, any combination thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iv) </B><B>Additional Restrictions. </B>At the time of the grant of a Restricted Stock Unit Award, the Board, as it deems appropriate, may
impose such restrictions or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent) subject to a Restricted Stock Unit Award to a time after the vesting of such Restricted Stock Unit Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(v) </B><B>Dividend Equivalents. </B>Dividend equivalents may be credited in respect of shares of Common Stock covered by a Restricted
Stock Unit Award, as determined by the Board and contained in the Restricted Stock Unit Award Agreement. At the sole discretion of the Board, such dividend equivalents may be converted into additional shares of Common Stock covered by the Restricted
Stock Unit Award in such manner as determined by the Board. Any additional shares covered by the Restricted Stock Unit Award credited by reason of such dividend equivalents will be subject to all of the same terms and conditions of the underlying
Restricted Stock Unit Award Agreement to which they relate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(vi) </B><B>Termination of Participant</B><B>&#146;</B><B>s Continuous
Service. </B>Except as otherwise provided in the applicable Restricted Stock Unit Award Agreement, such portion of the Restricted Stock Unit Award that has not vested will be forfeited upon the Participant&#146;s termination of Continuous Service.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c) Performance Stock Awards. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i) </B><B>Performance Stock Awards</B><B>.</B> A Performance Stock Award is a Stock Award that is payable (including that may be granted,
may vest or may be exercised) contingent upon the attainment during a Performance Period of certain Performance Goals. A Performance Stock Award may but need not require the Participant&#146;s completion of a specified period of Continuous Service.
The length of any Performance Period, the Performance Goals to be achieved during the Performance Period, and the measure of whether and to what degree such Performance Goals have been attained will be conclusively determined by the Board or
Committee, in its sole discretion. In addition, to the extent permitted by applicable law and the applicable Stock Award Agreement, the Board may determine that cash may be used in payment of Performance Stock Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii) Board Discretion.</B> The Board retains the discretion to adjust or eliminate the compensation or economic benefit due upon attainment
of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for a Performance Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)
</B><B>Other Stock Awards</B><B>.</B> Other forms of Stock Awards valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof (e.g., options or stock rights with an exercise price or
strike price less than 100% of the Fair Market Value of the Common Stock at the time of grant) may be granted either alone or in addition to Stock Awards provided for under Section&nbsp;5 and the preceding provisions of this Section&nbsp;6. Subject
to the provisions of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Plan, a majority of the Company&#146;s Independent Directors or the Independent Compensation Committee will have sole and complete authority to determine the persons to whom and the time or
times at which such Other Stock Awards will be granted, the number of shares of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Stock Awards and all other terms and conditions of such Other Stock Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Availability of Shares.</B> The Company will keep available at all times the number of shares of Common Stock reasonably required to
satisfy then-outstanding Stock Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Compliance with Law.</B> The Company will seek to obtain from each regulatory commission or
agency, as necessary, such authority as may be required to grant Stock Awards and to issue and sell shares of Common Stock upon exercise or vesting of the Stock Awards; <I>provided, however</I>, that this undertaking will not require the Company to
register under the Securities Act the Plan or other securities or applicable laws, any Stock Award or any Common Stock issued or issuable pursuant to any such Stock Award. If, after reasonable efforts and at a reasonable cost, the Company is unable
to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary or advisable for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any liability for
failure to issue and sell Common Stock upon exercise or vesting of such Stock Awards unless and until such authority is obtained. A Participant will not be eligible for the grant of a Stock Award or the subsequent issuance of cash or Common Stock
pursuant to the Stock Award if such grant or issuance would be in violation of any applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c) No Obligation to Notify or
Minimize Taxes. </B>The Company will have no duty or obligation to any Participant to advise such holder as to the time or manner or tax treatment of exercising such Stock Award. Furthermore, the Company will have no duty or obligation to warn or
otherwise advise such holder of a pending termination or expiration of a Stock Award or a possible period in which the Stock Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of a Stock Award to the
holder of such Stock Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. M<SMALL>ISCELLANEOUS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Use of Proceeds from Sales of Common Stock. </B>Proceeds from the sale of shares of Common Stock pursuant to Stock Awards will
constitute general funds of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Corporate Action Constituting Grant of Stock Awards.</B> Corporate action constituting a
grant by the Company of a Stock Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Stock Award
is communicated to, or actually received or accepted by, the Participant. In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain terms (e.g., exercise
price, vesting schedule or number of shares) that are inconsistent with those in the Stock Award Agreement or related grant documents as a result of a clerical error in the papering of the Stock Award Agreement or related grant documents, the
corporate records will control and the Participant will have no legally binding right to the incorrect term in the Stock Award Agreement or related grant documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c) Stockholder Rights.</B> No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to,
any shares of Common Stock subject to a Stock Award unless and until (i)&nbsp;such Participant has satisfied all requirements for exercise of, or the issuance of shares of Common Stock under, the Stock Award pursuant to its terms, and (ii)&nbsp;the
issuance of the Common Stock subject to such Stock Award has been entered into the books and records of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d) No Employment or Other Service Rights.</B> Nothing in the Plan, any Stock Award
Agreement or any other instrument executed thereunder or in connection with any Stock Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time
the Stock Award was granted or will affect the right of the Company or an Affiliate to terminate (i)&nbsp;the employment of an Employee with or without notice and with or without cause, (ii)&nbsp;the service of a Consultant pursuant to the terms of
such Consultant&#146;s agreement with the Company or an Affiliate, or (iii)&nbsp;the service of a Director pursuant to the bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state or foreign jurisdiction
in which the Company or the Affiliate is domiciled or incorporated, as the case may be. Furthermore, to the extent the Company is not the employer of a Participant, the grant of a Stock Award will be not establish an employment or other service
relationship between the Company and the Participant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e) Change in Time Commitment.</B> In the event a Participant&#146;s regular
level of time commitment in the performance of his or her services for the Company and any Affiliates is reduced (for example, and without limitation, if the Participant is an Employee of the Company and the Employee has a change in status from a
full-time Employee to a part-time Employee or takes an extended leave of absence) after the date of grant of any Stock Award to the Participant, the Board has the right in its sole discretion to (x)&nbsp;make a corresponding reduction in the number
of shares or cash amount subject to any portion of such Stock Award that is scheduled to vest or become payable after the date of such change in time commitment, and (y)&nbsp;in lieu of or in combination with such a reduction, extend the vesting or
payment schedule applicable to such Stock Award. In the event of any such reduction, the Participant will have no right with respect to any portion of the Stock Award that is so reduced. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f) Investment Assurances.</B> The Company may require a Participant, as a condition of exercising or acquiring Common Stock under any
Stock Award, (i)&nbsp;to give written assurances satisfactory to the Company as to the Participant&#146;s knowledge and experience in financial and business matters and/or to employ a purchaser representative reasonably satisfactory to the Company
who is knowledgeable and experienced in financial and business matters and that such Participant is capable of evaluating, alone or together with the purchaser representative, the merits and risks of exercising the Stock Award; and (ii)&nbsp;to give
written assurances satisfactory to the Company stating that the Participant is acquiring Common Stock subject to the Stock Award for the Participant&#146;s own account and not with any present intention of selling or otherwise distributing the
Common Stock. The foregoing requirements, and any assurances given pursuant to such requirements, will be inoperative if (A)&nbsp;the issuance of the shares upon the exercise or acquisition of Common Stock under the Stock Award has been registered
under a then currently effective registration statement under the Securities Act, or (B)&nbsp;as to any particular requirement, a determination is made by counsel for the Company that such requirement need not be met in the circumstances under the
then applicable securities laws. The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply with applicable securities laws,
including, but not limited to, legends restricting the transfer of the Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g) Withholding Obligations.</B> Unless
prohibited by the terms of a Stock Award Agreement, the Company may, in its sole discretion, satisfy any U.S. and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> federal, state or local tax withholding obligation relating to a Stock Award by any of
the following means or by a combination of such means: (i)&nbsp;causing the Participant to tender a cash payment; (ii)&nbsp;withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in
connection with the Stock Award; <I>provided, however, </I>that (A)&nbsp;no shares of Common Stock are withheld with a value exceeding the maximum amount of tax that may be required to be withheld by law (or such other amount
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
as may be permitted while still avoiding classification of the Stock Award as a liability for financial accounting purposes) ), and (B)&nbsp;with respect to a Stock Award held by any Participant
who is subject to the filing requirements of Section&nbsp;16 of the Exchange Act, any such share withholding must be specifically approved by the Compensation Committee as the applicable method that must be used to satisfy the tax withholding
obligation or such share withholding procedure must otherwise satisfy the requirements for an exempt transaction under Section&nbsp;16(b) of the Exchange Act; (iii)&nbsp;withholding cash from a Stock Award settled in cash; (iv)&nbsp;withholding
payment from any amounts otherwise payable to the Participant; (v)&nbsp;by means of a &#147;cashless exercise&#148; pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board, or (vi)&nbsp;by such other method as
may be set forth in the Stock Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(h) Electronic Delivery.</B> Any reference herein to a &#147;written&#148; agreement or
document will include any agreement or document delivered electronically, filed publicly at <U>www.sec.gov</U> (or any successor website thereto) or posted on the Company&#146;s intranet (or other shared electronic medium controlled by the Company
to which the Participant has access). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(i) Deferrals.</B> To the extent permitted by applicable law, the Board, in its sole discretion,
may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Stock Award may be deferred and may establish programs and procedures for deferral elections to be made by
Participants. Deferrals by Participants will be made in accordance with Section&nbsp;409A of the Code. Consistent with Section&nbsp;409A of the Code, the Board may provide for distributions while a Participant is still an employee or otherwise
providing services to the Company. The Board is authorized to make deferrals of Stock Awards and determine when, and in what annual percentages, Participants may receive payments, including lump sum payments, following the Participant&#146;s
termination of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance with applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(j) Compliance with Section</B><B></B><B>&nbsp;409A of the Code. </B>Unless otherwise expressly provided for in a Stock Award Agreement,
the Plan and Stock Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan and the Stock Awards granted hereunder exempt from Section&nbsp;409A of the Code, and, to the extent not so exempt, in compliance
with Section&nbsp;409A of the Code. If the Board determines that any Stock Award granted hereunder is not exempt from and is therefore subject to Section&nbsp;409A of the Code, the Stock Award Agreement evidencing such Stock Award will incorporate
the terms and conditions necessary to avoid the consequences specified in Section&nbsp;409A(a)(1) of the Code, and to the extent a Stock Award Agreement is silent on terms necessary for compliance, such terms are hereby incorporated by reference
into the Stock Award Agreement. Notwithstanding anything to the contrary in this Plan (and unless the Stock Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded, and if a Participant holding a Stock
Award that constitutes &#147;deferred compensation&#148; under Section&nbsp;409A of the Code is a &#147;specified employee&#148; for purposes of Section&nbsp;409A of the Code, no distribution or payment of any amount that is due because of a
&#147;separation from service&#148; (as defined in Section&nbsp;409A of the Code without regard to alternative definitions thereunder) will be issued or paid before the date that is six months following the date of such Participant&#146;s
&#147;separation from service&#148; or, if earlier, the date of the Participant&#146;s death, unless such distribution or payment can be made in a manner that complies with Section&nbsp;409A of the Code, and any amounts so deferred will be paid in a
lump sum on the day after such six month period elapses, with the balance paid thereafter on the original schedule. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(k)
Clawback/Recovery</B>. All Stock Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or
association on which the Company&#146;s securities are listed or as is otherwise required by the U.S. Dodd-Frank Wall Street Reform and Consumer Protection </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Act or other applicable law. In addition, the Board may impose such other clawback, recovery or recoupment provisions in a Stock Award Agreement as the Board determines necessary or appropriate,
including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of an event constituting Cause. No recovery of compensation under such a clawback policy will
be an event giving rise to a right to resign for &#147;good reason&#148; or &#147;constructive termination&#148; (or similar term) under any agreement with the Company or an Affiliate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. A<SMALL>DJUSTMENTS</SMALL> <SMALL>UPON</SMALL> C<SMALL>HANGES</SMALL> <SMALL>IN</SMALL> C<SMALL>OMMON</SMALL> S<SMALL>TOCK</SMALL>; O<SMALL>THER</SMALL>
C<SMALL>ORPORATE</SMALL> E<SMALL>VENTS</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Capitalization Adjustments.</B> In the event of a Capitalization Adjustment,
the Board will appropriately and proportionately adjust: (i)&nbsp;the class(es) and maximum number of securities subject to the Plan pursuant to Section&nbsp;3(a), and (ii)&nbsp;the class(es) and number of securities and price per share of stock
subject to outstanding Stock Awards. The Board will make such adjustments, and its determination will be final, binding and conclusive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Dissolution or Liquidation.</B> Except as otherwise provided in the Stock Award Agreement, in the event of a dissolution or liquidation
of the Company, all outstanding Stock Awards (other than Stock Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture condition or the Company&#146;s right of repurchase) will terminate immediately prior to
the completion of such dissolution or liquidation, and the shares of Common Stock subject to the Company&#146;s repurchase rights or subject to a forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the
holder of such Stock Award is providing Continuous Service; <I>provided, however</I>, that the Board may, in its sole discretion, cause some or all Stock Awards to become fully vested, exercisable and/or no longer subject to repurchase or forfeiture
(to the extent such Stock Awards have not previously expired or terminated) before the dissolution or liquidation is completed but contingent on its completion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c) Corporate Transaction.</B> The following provisions will apply to Stock Awards in the event of a Corporate Transaction unless otherwise
provided in the Stock Award Agreement or any other written agreement between the Company or any Affiliate and the Participant or unless otherwise expressly provided by the Board at the time of grant of a Stock Award. In the event of a Corporate
Transaction, then, notwithstanding any other provision of the Plan, the Board may take one or more of the following actions with respect to Stock Awards, contingent upon the closing or completion of the Corporate Transaction: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i) </B>arrange for the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#146;s parent company) to
assume or continue the Stock Award or to substitute a similar stock award for the Stock Award (including, but not limited to, an award to acquire the same consideration paid to the stockholders of the Company pursuant to the Corporate Transaction);
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii) </B>arrange for the assignment of any reacquisition or repurchase rights held by the Company in respect of Common Stock issued
pursuant to the Stock Award to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#146;s parent company); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii) </B>accelerate the vesting, in whole or in part, of the Stock Award (and, if applicable, the time at which the Stock Award may be
exercised) to a date prior to the effective time of such Corporate Transaction as the Board determines (or, if the Board does not determine such a date, to the date that is five days prior to the effective date of the Corporate Transaction), which
exercise is contingent upon the effectiveness of such Corporate Transaction with such Stock Award terminating if not exercised (if applicable) at or prior to the effective time of the Corporate Transaction; <I>provided, however</I>, that the Board
may require Participants to complete and deliver to the Company a notice of exercise before the effective date of a Corporate Transaction; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iv) </B>arrange for the lapse, in whole or in part, of any reacquisition or repurchase
rights held by the Company with respect to the Stock Award; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(v) </B>cancel or arrange for the cancellation of the Stock Award, to the
extent not vested or not exercised prior to the effective time of the Corporate Transaction, in exchange for such cash consideration, if any, as the Board, in its sole discretion, may consider appropriate; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(vi) </B>make a payment, in such form as may be determined by the Board equal to the excess, if any, of (A)&nbsp;the per share amount (or
value of property per share) payable to holders of Common Stock in connection with the Corporate Transaction, over (B)&nbsp;the per share exercise price under the applicable Stock Award, multiplied by the number of shares subject to the Stock Award.
For clarity, this payment may be zero (U.S. $0) if the amount per share (or value of property per share) payable to the holders of the Common Stock is equal to or less than the exercise price of the Stock Award. In addition, any escrow, holdback,
earnout or similar provisions in the definitive agreement for the Corporate Transaction may apply to such payment to the holder of the Stock Award to the same extent and in the same manner as such provisions apply to the holders of Common Stock.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board need not take the same action or actions with respect to all Stock Awards or portions thereof or with respect to all
Participants. The Board may take different actions with respect to the vested and unvested portions of a Stock Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d) Change in
Control.</B> A Stock Award may be subject to additional acceleration of vesting and exercisability upon or after a Change in Control as may be provided in the Stock Award Agreement for such Stock Award or as may be provided in any other written
agreement between the Company or any Affiliate and the Participant, but in the absence of such provision, no such acceleration will occur. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10.
</B><B>T<SMALL>ERMINATION</SMALL> <SMALL>OR</SMALL> S<SMALL>USPENSION</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>.</B> The Board may suspend or terminate the Plan at any time. No Stock Awards may be granted under the Plan while
the Plan is suspended or after it is terminated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. </B><B>E<SMALL>FFECTIVE</SMALL> <SMALL>DATE</SMALL>.</B> The Plan will become effective on the
Effective Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. </B><B>C<SMALL>HOICE</SMALL> <SMALL>OF</SMALL> L<SMALL>AW</SMALL>.</B> The law of the State of Delaware will govern all questions
concerning the construction, validity and interpretation of this Plan, without regard to that state&#146;s conflict of laws rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13.
</B><B>D<SMALL>EFINITIONS</SMALL>.</B> As used in the Plan, the following definitions will apply to the capitalized terms indicated below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a) </B>&#147;<B><I>Affiliate</I></B>&#148; means, at the time of determination, any &#147;parent&#148; or &#147;subsidiary&#148; of the
Company as such terms are defined in Rule 405 of the Securities Act. The Board will have the authority to determine the time or times at which &#147;parent&#148; or &#147;subsidiary&#148; status is determined within the foregoing definition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) </B>&#147;<B><I>Board</I></B>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> &#147;<B><I>Capital Stock</I></B>&#148;<I> </I>means each and every class of common stock of the Company, regardless of the number
of votes per share. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> &#147;<B><I>Capitalization Adjustment</I></B>&#148; means any change that is made
in, or other events that occur with respect to, the Common Stock subject to the Plan or subject to any Stock Award after the Effective Date without the receipt of consideration by the Company through merger, consolidation, reorganization,
recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate
structure or any similar equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the
conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e)
</B>&#147;<B><I>Cause</I></B>&#148;<I> </I>will have the meaning ascribed to such term in any written agreement between the Participant and the Company defining such term and, in the absence of such agreement, such term means, with respect to a
Participant, the occurrence of any of the following events: (i)&nbsp;such Participant&#146;s commission of any felony or any crime involving fraud, dishonesty or moral turpitude under the laws of the United States, any state thereof, or any
applicable foreign jurisdiction; (ii)&nbsp;such Participant&#146;s attempted commission of, or participation in, a fraud or act of dishonesty against the Company or any Affiliate; (iii)&nbsp;such Participant&#146;s intentional, material violation of
any contract or agreement between the Participant and the Company or any Affiliate, of any policy of the Company or any Affiliate applicable to Participant or of any statutory or fiduciary duty owed to the Company or any Affiliate; (iv)&nbsp;such
Participant&#146;s unauthorized use or disclosure of the Company&#146;s or any Affiliate&#146;s confidential information or trade secrets; or (v)&nbsp;such Participant&#146;s gross misconduct. The determination that a termination of the
Participant&#146;s Continuous Service is either for Cause or without Cause shall be made by the Company in its sole discretion. Any determination by the Company that the Continuous Service of a Participant was terminated by reason of dismissal
without Cause for the purposes of outstanding Stock Awards held by such Participant shall have no effect upon any determination of the rights or obligations of the Company or such Participant for any other purpose. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f) </B>&#147;<B><I>Change in Control</I></B>&#148; means the occurrence, in a single transaction or in a series of related transactions,
of any one or more of the following events: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i) </B>any Exchange Act Person becomes the Owner, directly or indirectly, of securities of
the Company representing more than 50% of the combined voting power of the Company&#146;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction. Notwithstanding the foregoing, a Change in Control will not
be deemed to occur (A)&nbsp;on account of the acquisition of securities of the Company directly from the Company, (B)&nbsp;on account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act
Person that acquires the Company&#146;s securities in a transaction or series of related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities, or (C)&nbsp;solely because the level
of Ownership held by any Exchange Act Person (the &#147;<B><I>Subject Person</I></B>&#148;) exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the
Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the
Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the
designated percentage threshold, then a Change in Control will be deemed to occur; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii) </B>there is consummated a merger,
consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own,
directly or indirectly, either (A)&nbsp;outstanding voting securities representing more than 50% of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B)&nbsp;more than 50% of the combined outstanding voting power of the parent of
the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii) </B>there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets
of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, more than 50% of the combined voting power of the
voting securities of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other disposition; or
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iv) </B>individuals who, on the Effective Date, are members of the Board (the &#147;<B><I>Incumbent Board</I></B>&#148;) cease for
any reason to constitute at least a majority of the members of the Board; <I>provided, however</I>, that if the appointment or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the
members of the Incumbent Board then still in office, such new member will, for purposes of this Plan, be considered as a member of the Incumbent Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing or any other provision of the Plan, the term Change in Control will not include a sale of assets, merger or
other transaction effected exclusively for the purpose of changing the domicile of the Company and the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any Affiliate and the
Participant will supersede the foregoing definition with respect to Stock Awards subject to such agreement; <I>provided, however</I>, that if no definition of Change in Control or any analogous term is set forth in such an individual written
agreement, the foregoing definition will apply. To the extent required for compliance with Section&nbsp;409A of the Code, in no event will a Change in Control be deemed to have occurred if such transaction is not also a &#147;change in the ownership
or effective control of&#148; the Company or &#147;a change in the ownership of a substantial portion of the assets of&#148; the Company as determined under Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(i)(5)</FONT>
(without regard to any alternative definition thereunder). The Board may, in its sole discretion and without a Participant&#146;s consent, amend the definition of &#147;Change in Control&#148; to conform to the definition of &#147;Change in
Control&#148; under Section&nbsp;409A of the Code, and the regulations thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g) </B>&#147;<B><I>Code</I></B>&#148; means the
Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(h)
</B>&#147;<B><I>Committee</I></B>&#148; means a committee of one or more Independent Directors to whom authority has been delegated by the Board in accordance with Section&nbsp;2(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(i) </B>&#147;<B><I>Common Stock</I></B>&#148; means the Class&nbsp;A shares of Company common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(j) </B>&#147;<B><I>Company</I></B>&#148; means NeuroPace, Inc., a Delaware corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(k) </B>&#147;<B><I>Consultant</I></B>&#148; means any person, including an advisor, who is (i)&nbsp;engaged by the Company or an Affiliate
to render consulting or advisory services and is compensated for such services, or (ii)&nbsp;serving as a member of the board of directors of an Affiliate and is compensated for such services. However, service solely as a Director, or payment of a
fee for such service, will not cause a Director to be considered a &#147;Consultant&#148; for purposes of the Plan.<B><I> </I></B>Notwithstanding the foregoing, a person is treated as a Consultant under this Plan only if a Form <FONT
STYLE="white-space:nowrap">S-8</FONT> Registration Statement under the Securities Act is available to register either the offer or the sale of the Company&#146;s securities to such person. Consultants are not eligible to receive Stock Awards under
the Plan with respect to their service in such capacity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(l) </B>&#147;<B><I>Continuous Service</I></B>&#148; means that the Participant&#146;s
service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Consultant
or Director or a change in the Entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#146;s service with the Company or an Affiliate, will not terminate a Participant&#146;s
Continuous Service; <I>provided, however</I>,<I> </I>that if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, in its sole discretion, such Participant&#146;s Continuous Service
will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate. For example, a change in status from an Employee of the Company to a Consultant of an Affiliate or to a Director will not constitute an interruption of
Continuous Service. To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#146;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i)&nbsp;any
leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii)&nbsp;transfers between the Company, an Affiliate, or their successors. Notwithstanding the foregoing, a
leave of absence will be treated as Continuous Service for purposes of vesting in a Stock Award only to such extent as may be provided in the Company&#146;s leave of absence policy, in the written terms of any leave of absence agreement or policy
applicable to the Participant, or as otherwise required by law. In addition, to the extent required for exemption from or compliance with Section&nbsp;409A of the Code, the determination of whether there has been a termination of Continuous Service
will be made, and such term will be construed, in a manner that is consistent with the definition of &#147;separation from service&#148; as defined under Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(h)</FONT> (without
regard to any alternative definition thereunder). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(m) </B>&#147;<B><I>Corporate Transaction</I></B>&#148; means the consummation, in a
single transaction or in a series of related transactions, of any one or more of the following events: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i) </B>a sale<B> </B>or other
disposition of all or substantially all, as determined by the Board, in its sole discretion, of the consolidated assets of the Company and its Subsidiaries; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii) </B>a sale or other disposition of more than 50% of the outstanding securities of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii) </B>a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iv) </B>a merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common
Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If required for compliance with Section&nbsp;409A of the Code, in no event will a Corporate Transaction be deemed to have
occurred if such transaction is not also a &#147;change in the ownership or effective control of&#148; the Company or &#147;a change in the ownership of a substantial portion of the assets of&#148; the Company as determined under Treasury Regulation
<FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(i)(5)</FONT> (without regard to any alternative definition thereunder). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(n) </B>&#147;<B><I>Director</I></B>&#148; means a member of the Board. Directors are not
eligible to receive Stock Awards under the Plan with respect to their service in such capacity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(o)
</B>&#147;<B><I>Disability</I></B>&#148; means, with respect to a Participant, the inability of such Participant to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected
to result in death or that has lasted or can be expected to last for a continuous period of not less than 12 months, as provided in Sections 22(e)(3) and 409A(a)(2)(c)(i) of the Code, and will be determined by the Board on the basis of such medical
evidence as the Board deems warranted under the circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(p) </B>&#147;<B><I>Effective Date</I></B>&#148; means July&nbsp;18,
2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(q) </B>&#147;<B><I>Employee</I></B>&#148; means any person employed by the Company or an Affiliate. However, service solely as
a Director, or payment of a fee for such services, will not cause a Director to be considered an &#147;Employee&#148; for purposes of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(r) </B>&#147;<B><I>Entity</I></B>&#148; means a corporation, partnership, limited liability company or other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(s) </B>&#147;<B><I>Exchange Act</I></B>&#148; means the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(t) </B>&#147;<B><I>Exchange Act Person</I></B>&#148;<B><I> </I></B>means any natural person, Entity or
&#147;group&#148; (within the meaning of Section&nbsp;13(d) or 14(d) of the Exchange Act), except that &#147;Exchange Act Person&#148; will not include (i)&nbsp;the Company or any Subsidiary of the Company, (ii)&nbsp;any employee benefit plan of the
Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii)&nbsp;an underwriter temporarily holding securities pursuant to a
registered public offering of such securities, (iv)&nbsp;an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company; or (v)&nbsp;any natural person,
Entity or &#147;group&#148; (within the meaning of Section&nbsp;13(d) or 14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting
power of the Company&#146;s then outstanding securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(u) </B>&#147;<B><I>Fair Market Value</I></B>&#148; means, as of any date,
the value of the Common Stock determined as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i) </B>If the Common Stock is listed on any established stock exchange or traded
on any established market, the Fair Market Value of a share of Common Stock will be, unless otherwise determined by the Board, the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest
volume of trading in the Common Stock) on the date of determination, as reported in a source the Board deems reliable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii) </B>Unless
otherwise provided by the Board, if there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii) </B>In the absence of such markets for the Common Stock, the Fair Market Value will be determined by the Board in good faith and in a
manner that complies with Sections 409A and 422 of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(v) </B>&#147;<B><I><FONT STYLE="white-space:nowrap">Non-Employee</FONT>
Director</I></B>&#148;<B> </B>means a Director who either (i)&nbsp;is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services
rendered as a consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated pursuant to the
Securities Act (&#147;<B><I>Regulation <FONT STYLE="white-space:nowrap">S-K</FONT></I></B>&#148;)), does not possess an interest in any other transaction for which disclosure would be required under Item 404(a) of Regulation <FONT
STYLE="white-space:nowrap">S-K,</FONT> and is not engaged in a business relationship for which disclosure would be required pursuant to Item&nbsp;404(b) of Regulation <FONT STYLE="white-space:nowrap">S-K;</FONT> or (ii)&nbsp;is otherwise considered
a <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> director&#148; for purposes of Rule <FONT STYLE="white-space:nowrap">16b-3.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(w) </B>&#147;<B><I>Nonstatutory Stock Option</I></B>&#148; means any Option granted pursuant to Section&nbsp;5 of the Plan that does not
qualify as an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(x)
</B>&#147;<B><I>Officer</I></B>&#148; means a person who is an officer of the Company within the meaning of Section&nbsp;16 of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(y) </B>&#147;<B><I>Option</I></B>&#148; means a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(z) </B>&#147;<B><I>Option Agreement</I></B>&#148; means a written agreement between the Company and an Optionholder evidencing the
terms and conditions of an Option grant. Each Option Agreement will be subject to the terms and conditions of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(aa)
</B>&#147;<B><I>Optionholder</I></B>&#148; means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(bb) </B>&#147;<B><I>Other Stock Award</I></B>&#148; means an award based in whole or in part by reference to the Common Stock which is
granted pursuant to the terms and conditions of Section&nbsp;6(d). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(cc) </B>&#147;<B><I>Other Stock Award
Agreement</I></B>&#148;<B><I> </I></B>means a written agreement between the Company and a holder of an Other Stock Award evidencing the terms and conditions of an Other Stock Award grant. Each Other Stock Award Agreement will be subject to the terms
and conditions of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(dd) </B>&#147;<B><I>Own,</I></B>&#148;<B><I> </I></B>&#147;<B><I>Owned,</I></B>&#148;<B><I>
</I></B>&#147;<B><I>Owner,</I></B>&#148;<B><I> </I></B>&#147;<B><I>Ownership</I></B>&#148;<B> </B>means a person or Entity will be deemed to &#147;Own,&#148; to have &#147;Owned,&#148; to be the &#147;Owner&#148; of, or to have acquired
&#147;Ownership&#148; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting,
with respect to such securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ee) </B>&#147;<B><I>Parent</I></B>&#148; means any corporation (other than the Company) in an
unbroken chain of corporations ending with the Company, if each of the corporations other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A
corporation that attains the status of a Parent on a date after the adoption of the Plan shall be considered a Parent commencing as of such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ff) </B>&#147;<B><I>Participant</I></B>&#148; means a person to whom a Stock Award is granted pursuant to the Plan or, if applicable, such
other person who holds an outstanding Stock Award. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(gg) </B>&#147;<B><I>Performance Criteria</I></B>&#148; means the one or more criteria
that a majority of the Company&#146;s Independent Directors or the Independent Compensation Committee (as applicable) will select for purposes of establishing the Performance Goals for a Performance Period. The Performance Criteria that will be used
to establish such Performance Goals may be based on any one of, or combination of, the following as determined by a majority of the Company&#146;s Independent Directors or the Independent Compensation Committee (as applicable): (1) earnings
(including earnings per share and net earnings); (2) earnings before interest, taxes, depreciation and amortization; (3)&nbsp;total stockholder return; (4)&nbsp;return on equity or average stockholder&#146;s equity; (5)&nbsp;return on assets,
investment, or capital employed; (6)&nbsp;stock price; (7)&nbsp;margin (including gross margin); (8) income (before or after taxes); (9) operating income; (10)&nbsp;operating income after taxes;
<FONT STYLE="white-space:nowrap">(11)&nbsp;pre-tax</FONT> profit; (12)&nbsp;operating cash flow; (13)&nbsp;sales or revenue targets; (14)&nbsp;increases in revenue or product revenue; (15)&nbsp;expenses and cost reduction goals;
(16)&nbsp;improvement in or attainment of working capital levels; (17)&nbsp;economic value added (or an equivalent metric); (18) market share; (19)&nbsp;cash flow; (20)&nbsp;cash flow per share; (21)&nbsp;share price performance; (22)&nbsp;debt
reduction; (23)&nbsp;customer satisfaction; (24)&nbsp;stockholders&#146; equity; (25)&nbsp;capital expenditures; (26)&nbsp;debt levels; (27)&nbsp;operating profit or net operating profit; (28)&nbsp;workforce diversity; (29)&nbsp;growth of net income
or operating income; (30)&nbsp;billings; (31) implementation or completion of projects or processes; (32)&nbsp;financing; (33) regulatory milestones; (34)&nbsp;stockholder liquidity; (35)&nbsp;corporate governance and compliance; (36)&nbsp;product
commercialization; (37)&nbsp;intellectual property; (38)&nbsp;personnel matters; (39)&nbsp;progress of internal research or clinical programs; (40)&nbsp;progress of partnered programs; (41)&nbsp;partner satisfaction; (42)&nbsp;budget management;
(43)&nbsp;clinical achievements; (44)&nbsp;completing phases of a clinical study (including the treatment phase); (45) announcing or presenting preliminary or final data from clinical studies; in each case, whether on particular timelines or
generally; (46)&nbsp;timely completion of clinical trials; (47)&nbsp;submission of Device Master File(s) and other regulatory achievements; (48)&nbsp;partner or collaborator achievements; (49)&nbsp;internal controls, including those related to the
Sarbanes-Oxley Act of 2002; (50) research progress, including the development of programs; (51)&nbsp;investor relations, analysts and communication; (52)&nbsp;manufacturing achievements (including obtaining particular yields from manufacturing runs
and other measurable objectives related to process development activities); (53) strategic partnerships or transactions (including <FONT STYLE="white-space:nowrap">in-licensing</FONT> and <FONT STYLE="white-space:nowrap">out-licensing</FONT> of
intellectual property; (54)&nbsp;establishing relationships with commercial entities with respect to the marketing, distribution and sale of the Company&#146;s products and services (including with group purchasing organizations, distributors and
other vendors); (55) supply chain achievements (including establishing relationships with manufacturers, suppliers and other services providers of the Company&#146;s products and services); (56)
<FONT STYLE="white-space:nowrap">co-development,</FONT> <FONT STYLE="white-space:nowrap">co-marketing,</FONT> profit sharing, joint venture or other similar arrangements; (57)&nbsp;individual performance goals; (58)&nbsp;corporate development and
planning goals; and (59)&nbsp;other measures of performance selected a majority of the Company&#146;s Independent Directors or the Independent Compensation Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(hh) </B>&#147;<B><I>Performance Goals</I></B>&#148; means, for a Performance Period, the one or more goals established by a majority of
the Company&#146;s Independent Directors or the Independent Compensation Committee (as applicable) for the Performance Period based upon the Performance Criteria. Performance Goals may be based on a Company-wide basis, with respect to one or more
business units, divisions, Affiliates, or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise by
Company&#146;s Independent Directors or the Independent Compensation Committee (as applicable)&nbsp;(i) in the Stock Award Agreement at the time the Stock Award is granted or (ii)&nbsp;in such other document setting forth the Performance Goals at
the time the Performance Goals are established, the Company&#146;s Independent Directors or the Independent Compensation Committee (as applicable) will appropriately make adjustments in the method of calculating the attainment of Performance Goals
for a Performance Period as follows: (1)&nbsp;to exclude restructuring and/or other nonrecurring charges; (2)&nbsp;to exclude exchange rate effects; (3)&nbsp;to exclude the effects of changes to generally accepted accounting principles; (4)&nbsp;to
exclude the effects of any statutory adjustments to corporate tax rates; (5)&nbsp;to exclude the effects of items that are &#147;unusual&#148; in nature or occur &#147;infrequently&#148; as determined under generally accepted accounting principles;
(6)&nbsp;to exclude the dilutive effects of acquisitions or joint ventures; (7)&nbsp;to assume that any business divested by the Company achieved performance objectives at targeted levels </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
during the balance of a Performance Period following such divestiture; (8)&nbsp;to exclude the effect of any change in the outstanding shares of common stock of the Company by reason of any stock
dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, <FONT STYLE="white-space:nowrap">spin-off,</FONT> combination or exchange of shares or other similar corporate change, or any distributions to common
stockholders other than regular cash dividends; (9)&nbsp;to exclude the effects of stock based compensation and the award of bonuses under the Company&#146;s bonus plans; (10)&nbsp;to exclude costs incurred in connection with potential acquisitions
or divestitures that are required to be expensed under generally accepted accounting principles; (11)&nbsp;to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting
principles and (12)&nbsp;to exclude the effect of any other unusual, nonrecurring gain or loss or other extraordinary item. In addition, the Company&#146;s Independent Directors or the Independent Compensation Committee (as applicable) retains the
discretion to reduce or eliminate the compensation or economic benefit due upon attainment of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for such Performance Period. Partial achievement of
the specified criteria may result in the payment or vesting corresponding to the degree of achievement as specified in the Stock Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ii) </B>&#147;<B><I>Performance Period</I></B>&#148; means the period of time selected by a majority of the Company&#146;s Independent
Directors or the Independent Compensation Committee (as applicable) over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#146;s right to and the payment of a Stock Award.
Performance Periods may be of varying and overlapping duration, at the sole discretion of a majority of the Company&#146;s Independent Directors or the Independent Compensation Committee (as applicable). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(jj) </B>&#147;<B><I>Performance Stock Award</I></B>&#148; means a Stock Award granted under the terms and conditions of
Section&nbsp;6(c)(i). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(kk) </B>&#147;<B><I>Plan</I></B>&#148; means this NeuroPace, Inc. 2023 Inducement Plan, as it may be amended
from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ll) </B>&#147;<B><I>Restricted Stock Award</I></B>&#148; means an award of shares of Common Stock which is granted
pursuant to the terms and conditions of Section&nbsp;6(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(mm) </B>&#147;<B><I>Restricted Stock Award Agreement</I></B>&#148; means a
written agreement between the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant. Each Restricted Stock Award Agreement will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(nn) </B>&#147;<B><I>Restricted Stock Unit Award</I></B>&#148;<B><I> </I></B>means a right to receive shares of Common Stock which is
granted pursuant to the terms and conditions of Section&nbsp;6(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(oo) </B>&#147;<B><I>Restricted Stock Unit Award
Agreement</I></B>&#148;<B><I> </I></B>means a written agreement between the Company and a holder of a Restricted Stock Unit Award evidencing the terms and conditions of a Restricted Stock Unit Award grant. Each Restricted Stock Unit Award Agreement
will be subject to the terms and conditions of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(pp) </B>&#147;<B><I>Rule
<FONT STYLE="white-space:nowrap">16b-3</FONT></I></B>&#148; means Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act or any successor to Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> as in effect from time to
time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(qq) </B>&#147;<B><I>Securities Act</I></B>&#148; means the Securities Act of 1933, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(rr) </B>&#147;<B><I>Stock Appreciation Right</I></B>&#148; or
&#147;<B><I>SAR</I></B>&#148;<B><I> </I></B>means a right to receive the appreciation on Common Stock that is granted pursuant to the terms and conditions of Section&nbsp;5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ss) </B>&#147;<B><I>Stock Appreciation Right Agreement</I></B>&#148; means a written agreement between the Company and a holder of a Stock
Appreciation Right evidencing the terms and conditions of a Stock Appreciation Right grant. Each Stock Appreciation Right Agreement will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(tt)</B> &#147;<B><I>Stock Award</I></B>&#148; means any right to receive Common Stock granted under the Plan, including a Nonstatutory
Stock Option, a Restricted Stock Award, a Restricted Stock Unit Award, a Stock Appreciation Right, a Performance Stock Award or any Other Stock Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(uu) </B>&#147;<B><I>Stock Award Agreement</I></B>&#148; means a written agreement between the Company and a Participant evidencing the
terms and conditions of a Stock Award grant. Each Stock Award Agreement will be subject to the terms and conditions of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(vv)
</B>&#147;<B><I>Subsidiary</I></B>&#148; means, with respect to the Company, (i)&nbsp;any corporation of which more than 50% of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such
corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the
Company, and (ii)&nbsp;any partnership, limited liability company or other entity in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than 50%. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>For U.S. Participants</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N<SMALL>EURO</SMALL>P<SMALL>ACE</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2023 I<SMALL>NDUCEMENT</SMALL> P<SMALL>LAN</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>TOCK</SMALL> O<SMALL>PTION</SMALL> G<SMALL>RANT</SMALL> N<SMALL>OTICE</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NeuroPace, Inc. (the &#147;<B><I>Company</I></B>&#148;), pursuant to its 2023 Inducement Plan (the &#147;<B><I>Plan</I></B>&#148;), hereby grants to
Optionholder an option to purchase the number of shares of the Company&#146;s Common Stock set forth below. This option is subject to all of the terms and conditions as set forth in this stock option grant notice (this &#147;<B><I>Stock Option Grant
Notice</I></B>&#148;), in the Stock Option Agreement, the Plan and the Notice of Exercise, all of which are attached hereto and incorporated herein in their entirety. Capitalized terms not explicitly defined herein but defined in the Plan or the
Stock Option Agreement will have the same definitions as in the Plan or the Stock Option Agreement. If there is any conflict between the terms herein and the Plan, the terms of the Plan will control. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Optionholder:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date of Grant:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vesting Commencement Date:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of Shares Subject to Option:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise Price (Per Share):</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Exercise Price:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expiration Date:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Type of Grant: </B>Nonstatutory Stock Option </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exercise Schedule:</B> Same as Vesting Schedule </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vesting
Schedule:</B> [VESTING SCHEDULE] </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Payment:</B> By one or a combination of the following items (described in the Stock Option Agreement): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#9744; By cash, check, bank draft, wire transfer or money order payable to the Company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#9744; Pursuant to a Regulation T Program if the shares are publicly traded </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#9744; Subject to the Company&#146;s consent at the time of exercise, by a &#147;net exercise&#148; arrangement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Terms/Acknowledgements:</B> Optionholder acknowledges receipt of, and understands and agrees to, this Stock Option Grant Notice, the Stock
Option Agreement and the Plan. Optionholder acknowledges and agrees that this Stock Option Grant Notice and the Stock Option Agreement may not be modified, amended or revised except as provided in the Plan.<B> </B>Optionholder further acknowledges
that as of the Date of Grant, this Stock Option Grant Notice, the Stock Option Agreement, and the Plan set forth the entire understanding between Optionholder and the Company regarding this option award and supersede all prior oral and written
agreements, promises and/or representations on that subject with the exception of (i)&nbsp;options and other equity awards previously granted and delivered to Optionholder, (ii)&nbsp;any compensation recovery policy that is adopted by the Company or
is otherwise required by applicable law and (iii)&nbsp;any written employment or severance arrangement that would provide for vesting acceleration of this option upon the terms and conditions set forth therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>For U.S. Participants</I> </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By accepting this option, Optionholder consents to receive such documents by electronic delivery and to
participate in the Plan through an <FONT STYLE="white-space:nowrap">on-line</FONT> or electronic system established and maintained by the Company or another third party designated by the Company. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>N<SMALL>EURO</SMALL>P<SMALL>ACE</SMALL>, I<SMALL>NC</SMALL>. </B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"><B>O<SMALL>PTIONHOLDER</SMALL>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Signature</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Signature</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Date:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>A<SMALL>TTACHMENTS</SMALL></B><SMALL></SMALL>: Stock Option Agreement, 2023 Inducement Plan, Notice of Exercise </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>For U.S. Participants</I> </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ATTACHMENT I </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N<SMALL>EURO</SMALL>P<SMALL>ACE</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2023 I<SMALL>NDUCEMENT</SMALL> P<SMALL>LAN</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>TOCK</SMALL> O<SMALL>PTION</SMALL> A<SMALL>GREEMENT</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to your Stock Option Grant Notice (&#147;<B><I>Stock Option Grant Notice</I></B>&#148;) and this Stock Option Agreement (this
&#147;<B><I>Stock Option Agreement</I></B>&#148;), NeuroPace, Inc. (the &#147;<B><I>Company</I></B>&#148;) has granted you an option under its 2023 Inducement Plan (the &#147;<B><I>Plan</I></B>&#148;) to purchase the number of shares of the
Company&#146;s Common Stock indicated in your Stock Option Grant Notice at the exercise price indicated in your Stock Option Grant Notice. This option is granted in compliance with Nasdaq Listing Rule 5635(c)(4) as a material inducement to you
entering into employment with the Company. The option is granted to you effective as of the date of grant set forth in the Stock Option Grant Notice (the &#147;<B><I>Date of Grant</I></B>&#148;). If there is any conflict between the terms in this
Stock Option Agreement and the Plan, the terms of the Plan will control. Capitalized terms not explicitly defined in this Stock Option Agreement or in the Stock Option Grant Notice but defined in the Plan will have the same definitions as in the
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The details of your option, in addition to those set forth in the Stock Option Grant Notice and the Plan, are as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1. </B><B>V<SMALL>ESTING</SMALL>.</B> Your option will vest as provided in your Stock Option Grant Notice. Vesting will cease upon the
termination of your Continuous Service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2. </B><B>N<SMALL>UMBER</SMALL> <SMALL>OF</SMALL> S<SMALL>HARES</SMALL> <SMALL>AND</SMALL>
E<SMALL>XERCISE</SMALL> P<SMALL>RICE</SMALL>.</B> The number of shares of Common Stock subject to your option and your exercise price per share in your Stock Option Grant Notice will be adjusted for Capitalization Adjustments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3. </B><B>E<SMALL>XERCISE</SMALL> R<SMALL>ESTRICTION</SMALL> <SMALL>FOR</SMALL>
N<SMALL>ON</SMALL><FONT STYLE="white-space:nowrap">-E</FONT><SMALL>XEMPT</SMALL> E<SMALL>MPLOYEES</SMALL>.</B> If you are an Employee eligible for overtime compensation under the Fair Labor Standards Act of 1938, as amended (that is, a &#147;<B><I><FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Employee</I></B>&#148;), and except as otherwise provided in the Plan, you may not exercise your option until you have completed at least six (6)&nbsp;months of Continuous Service measured from the Date
of Grant, even if you have already been an employee for more than six (6)&nbsp;months. Consistent with the provisions of the Worker Economic Opportunity Act, you may exercise your option as to any vested portion prior to such six (6)&nbsp;month
anniversary in the case of (i)&nbsp;your death or disability, (ii)&nbsp;a Corporate Transaction in which your option is not assumed, continued or substituted, (iii)&nbsp;a Change in Control or (iv)&nbsp;your termination of Continuous Service on your
&#147;retirement&#148; (as defined in the Company&#146;s benefit plans). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4. </B><B>M<SMALL>ETHOD</SMALL> <SMALL>OF</SMALL>
P<SMALL>AYMENT</SMALL>.</B> You must pay the full amount of the exercise price for the shares you wish to exercise. You may pay the exercise price in cash or by check, bank draft, wire transfer or money order payable to the Company or in any other
manner permitted by your Stock Option Grant Notice<I>,</I> which may include, provided that at the time of exercise the Common Stock is publicly traded, pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board
that, prior to the issuance of Common Stock, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds (this manner of
payment is also known as a &#147;broker-assisted exercise&#148;, &#147;same day sale&#148;, or &#147;sell to cover&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I-1. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>For U.S. Participants</I> </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5. </B><B>W<SMALL>HOLE</SMALL> S<SMALL>HARES</SMALL>.</B> You may exercise your option
only for whole shares of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6. </B><B>S<SMALL>ECURITIES</SMALL> L<SMALL>AW</SMALL> C<SMALL>OMPLIANCE</SMALL>.</B> In no
event may you exercise your option unless the shares of Common Stock issuable upon exercise are then registered under the Securities Act or, if not registered, the Company has determined that your exercise and the issuance of the shares would be
exempt from the registration requirements of the Securities Act. The exercise of your option also must comply with all other applicable laws and regulations governing your option, and you may not exercise your option if the Company determines that
such exercise would not be in material compliance with such laws and regulations (including any restrictions on exercise required for compliance with Treas. Reg. <FONT STYLE="white-space:nowrap">1.401(k)-1(d)(3),</FONT> if applicable). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7. </B><B>T<SMALL>ERM</SMALL>.</B> You may not exercise your option before the Date of Grant or after the expiration of the option&#146;s
term. The term of your option expires, subject to the provisions of Section&nbsp;5(h) of the Plan, upon the earliest of the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a) </B>immediately upon the termination of your Continuous Service for Cause; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b) </B>three (3)&nbsp;months after the termination of your Continuous Service for any reason other than Cause, your Disability, or your
death (except as otherwise provided in Section&nbsp;7(d) below); <I>provided</I>,<I> however</I>,<I> </I>that if during any part of such three-month period your option is not exercisable solely because of the condition set forth in Section&nbsp;6
above relating to &#147;Securities Law Compliance,&#148; your option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three (3)&nbsp;months after the termination of your Continuous
Service; <I>provided further</I>, that if (i)&nbsp;you are a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Employee, (ii)&nbsp;your Continuous Service terminates within six (6)&nbsp;months after the Date of Grant, and (iii)&nbsp;you have vested
in a portion of your option at the time of your termination of Continuous Service, your option will not expire until the earlier of (x)&nbsp;the later of (A)&nbsp;the date that is seven (7)&nbsp;months after the Date of Grant, and (B)&nbsp;the date
that is three (3)&nbsp;months after the termination of your Continuous Service, and (y)&nbsp;the Expiration Date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c) </B>twelve
(12)&nbsp;months after the termination of your Continuous Service due to your Disability (except as otherwise provided in Section&nbsp;7(d)) below; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d) </B>eighteen (18)&nbsp;months after your death if you die either during your Continuous Service or within three (3)&nbsp;months after
your Continuous Service terminates for any reason other than Cause; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e) </B>the Expiration Date indicated in your Stock Option Grant
Notice; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f) </B>the day before the tenth (10th) anniversary of the Date of Grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8. E<SMALL>XERCISE</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a) </B>You may exercise the vested portion of your option during its term by (i)&nbsp;delivering a Notice of Exercise (in a form
designated by the Company) or completing such other documents and/or procedures designated by the Company for exercise and (ii)&nbsp;paying the exercise price and any applicable withholding taxes to the Company&#146;s Secretary, stock plan
administrator, or such other person as the Company may designate, together with such additional documents as the Company may then require. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I-2. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>For U.S. Participants</I> </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b) </B>By exercising your option you agree that, as a condition to any exercise of your
option, the Company may require you to enter into an arrangement providing for the payment by you to the Company of any tax withholding obligation of the Company arising by reason of (i)&nbsp;the exercise of your option, or (ii)&nbsp;the disposition
of shares of Common Stock acquired upon such exercise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c) </B>By exercising your option you agree that you will not sell, dispose of,
transfer, make any short sale of, grant any option for the purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale with respect to any shares of Common Stock or other securities of the Company held by
you, for a period of one hundred eighty (180)&nbsp;days following the effective date of a registration statement of the Company filed under the Securities Act or such longer period as the underwriters or the Company will request to facilitate
compliance with FINRA Rule 2241 or any successor or similar rules or regulation (the &#147;<B><I><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period</I></B>&#148;); <I>provided</I>,<I> however</I>, that nothing contained in this Section&nbsp;8(d)
will prevent the exercise of a repurchase option, if any, in favor of the Company during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period. You further agree to execute and deliver such other agreements as may be reasonably requested by the
Company or the underwriters that are consistent with the foregoing or that are necessary to give further effect thereto. In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to your shares of
Common Stock until the end of such period. You also agree that any transferee of any shares of Common Stock (or other securities) of the Company held by you will be bound by this Section&nbsp;8(d). The underwriters of the Company&#146;s stock are
intended third party beneficiaries of this Section&nbsp;8(d) and will have the right, power and authority to enforce the provisions hereof as though they were a party hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9. </B><B>T<SMALL>RANSFERABILITY</SMALL>.</B> Except as otherwise provided in this Section&nbsp;9, your option is not transferable, except
by will or by the laws of descent and distribution, and is exercisable during your life only by you. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a) </B><B>Certain Trusts.</B>
Upon receiving written permission from the Board or its duly authorized designee, you may transfer your option to a trust if you are considered to be the sole beneficial owner (determined under Section&nbsp;671 of the Code and applicable state law)
while the option is held in the trust. You and the trustee must enter into transfer and other agreements required by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)
</B><B>Domestic Relations Orders.</B> Upon receiving written permission from the Board or its duly authorized designee, and provided that you and the designated transferee enter into transfer and other agreements required by the Company, you may
transfer your option pursuant to the terms of a domestic relations order or official marital settlement agreement. You are encouraged to discuss the proposed terms of any division of this option with the Company prior to finalizing the domestic
relations order or marital settlement agreement to help ensure the required information is contained within the domestic relations order or marital settlement agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c) </B><B>Beneficiary Designation.</B> Upon receiving written permission from the Board or its duly authorized designee, you may, by
delivering written notice to the Company, in a form approved by the Company and any broker designated by the Company to handle option exercises, designate a third party who, on your death, will thereafter be entitled to exercise this option and
receive the Common Stock or other consideration resulting from such exercise. In the absence of such a designation, your executor or administrator of your estate will be entitled to exercise this option and receive, on behalf of your estate, the
Common Stock or other consideration resulting from such exercise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10. </B><B>R<SMALL>IGHT</SMALL> <SMALL>OF</SMALL>
R<SMALL>EPURCHASE</SMALL>.</B> The Company will have the right to repurchase all of the shares of Common Stock you acquire pursuant to the exercise of your option upon termination of your Continuous Service for Cause. Such repurchase will be at the
exercise price you paid to acquire the shares and will be effected pursuant to such other terms and conditions, and at such time, as the Company will determine. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I-3. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>For U.S. Participants</I> </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11. </B><B>O<SMALL>PTION</SMALL> <SMALL>NOT</SMALL> <SMALL>A</SMALL>
S<SMALL>ERVICE</SMALL> C<SMALL>ONTRACT</SMALL>.</B> Your option is not an employment or service contract, and nothing in your option will be deemed to create in any way whatsoever any obligation on your part to continue in the employ of the Company
or an Affiliate, or of the Company or an Affiliate to continue your employment. In addition, nothing in your option will obligate the Company or an Affiliate, their respective stockholders, boards of directors, officers or employees to continue any
relationship that you might have as a Director or Consultant for the Company or an Affiliate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12. W<SMALL>ITHHOLDING</SMALL>
O<SMALL>BLIGATIONS</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a) </B>At the time you exercise your option, in whole or in part, and at any time thereafter as
requested by the Company, you hereby authorize withholding from payroll and any other amounts payable to you, and otherwise agree to make adequate provision for (including by means of a &#147;same day sale&#148; pursuant to a program developed under
Regulation T as promulgated by the Federal Reserve Board to the extent permitted by the Company), any sums required to satisfy the federal, state, local and foreign income tax, social insurance, payroll tax, fringe benefit tax, payment on account or
other <FONT STYLE="white-space:nowrap">tax-related</FONT> withholding obligations of the Company or an Affiliate, if any, which arise in connection with the exercise of your option or the disposition of shares of Common Stock acquired upon such
exercise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b) </B>Upon your request and subject to approval by the Company, and compliance with any applicable legal conditions or
restrictions, the Company may withhold from fully vested shares of Common Stock otherwise issuable to you upon the exercise of your option a number of whole shares of Common Stock having a Fair Market Value, determined by the Company as of the date
of exercise, not in excess of the maximum amount of tax required to be withheld by law (or such other greater or lesser amount that avoids classification of your option as a liability for financial accounting purposes). Any adverse consequences to
you arising in connection with such share withholding procedure will be your sole responsibility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c) </B>You may not exercise your
option unless the tax withholding obligations of the Company and/or any Affiliate are satisfied. Accordingly, you may not be able to exercise your option when desired even though your option is vested, and the Company will have no obligation to
issue a certificate for such shares of Common Stock or release such shares of Common Stock from any escrow provided for herein, if applicable, unless such obligations are satisfied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13. </B><B>T<SMALL>AX</SMALL> C<SMALL>ONSEQUENCES</SMALL></B><SMALL></SMALL>. You hereby agree that the Company does not have a duty to
design or administer the Plan or its other compensation programs in a manner that minimizes your tax liabilities. You will not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates related to tax liabilities
arising from your option or your other compensation. In particular, you acknowledge that this option is exempt from Section&nbsp;409A of the Code only if the exercise price per share specified in the Stock Option Grant Notice is at least equal to
the &#147;fair market value&#148; per share of the Common Stock on the Date of Grant and there is no other impermissible deferral of compensation associated with the option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14. </B><B>N<SMALL>OTICES</SMALL>.</B> Any notices provided for in your option or the Plan will be given in writing (including
electronically) and will be deemed effectively given upon receipt or, in the case of notices delivered by mail by the Company to you, five (5)&nbsp;days after deposit in the United States mail, postage prepaid, addressed to you at the last address
you provided to the Company. The Company may, in its sole discretion, decide to deliver any documents related to participation in the Plan and this option by electronic means or to request your consent to participate in the Plan by electronic means.
By accepting this option, you consent to receive such documents by electronic delivery and to participate in the Plan through an <FONT STYLE="white-space:nowrap">on-line</FONT> or electronic system established and maintained by the Company or
another third party designated by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I-4. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>For U.S. Participants</I> </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15. </B><B>G<SMALL>OVERNING</SMALL> P<SMALL>LAN</SMALL>
D<SMALL>OCUMENT</SMALL></B><SMALL></SMALL>. Your option is subject to all the provisions of the Plan, the provisions of which are hereby made a part of your option, and is further subject to all interpretations, amendments, rules and regulations,
which may from time to time be promulgated and adopted pursuant to the Plan. If there is any conflict between the provisions of your option and those of the Plan, the provisions of the Plan will control. In addition, your option (and any
compensation paid or shares issued under your option) is subject to recoupment in accordance with The Dodd&#150;Frank Wall Street Reform and Consumer Protection Act and any implementing regulations thereunder, any clawback policy adopted by the
Company and any compensation recovery policy otherwise required by applicable law. No recovery of compensation under such a clawback policy will be an event giving rise to a right to voluntarily terminate employment upon a resignation for &#147;good
reason,&#148; or for a &#147;constructive termination&#148; or any similar term under any plan of or agreement with the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>16.
</B><B>O<SMALL>THER</SMALL> D<SMALL>OCUMENTS</SMALL></B><SMALL></SMALL>. You hereby acknowledge receipt of and the right to receive a document providing the information required by Rule 428(b)(1) promulgated under the Securities Act, which includes
the Plan prospectus. In addition, you acknowledge receipt of the Company&#146;s policy permitting certain individuals to sell shares only during certain &#147;window&#148; periods and the Company&#146;s insider trading policy, in effect from time to
time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17. </B><B>E<SMALL>FFECT</SMALL> <SMALL>ON</SMALL> O<SMALL>THER</SMALL> E<SMALL>MPLOYEE</SMALL> B<SMALL>ENEFIT</SMALL>
P<SMALL>LANS</SMALL></B><SMALL></SMALL>. The value of this option will not be included as compensation, earnings, salaries, or other similar terms used when calculating your benefits under any employee benefit plan sponsored by the Company or any
Affiliate, except as such plan otherwise expressly provides. The Company expressly reserves its rights to amend, modify, or terminate any of the Company&#146;s or any Affiliate&#146;s employee benefit plans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18. </B><B>V<SMALL>OTING</SMALL> R<SMALL>IGHTS</SMALL></B><SMALL></SMALL>. You will not have voting or any other rights as a shareholder of
the Company with respect to the shares to be issued pursuant to this option until such shares are issued to you. Upon such issuance, you will obtain full voting and other rights as a shareholder of the Company. Nothing contained in this option, and
no action taken pursuant to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between you and the Company or any other person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>19. </B><B>S<SMALL>EVERABILITY</SMALL></B><SMALL></SMALL>. If all or any part of this Stock Option Agreement or the Plan is declared by any
court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity will not invalidate any portion of this Stock Option Agreement or the Plan not declared to be unlawful or invalid. Any section of this Stock Option Agreement
(or part of such a section) so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such section or part of a section to the fullest extent possible while remaining lawful and valid.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>20. </B><B>N<SMALL>O</SMALL> A<SMALL>DVICE</SMALL> R<SMALL>EGARDING</SMALL> G<SMALL>RANT</SMALL></B><SMALL></SMALL>. The Company is
not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding your participation in the Plan, or your acquisition or sale of the underlying shares of stock. You are hereby advised to consult with your own
personal tax, legal and financial advisors regarding your participation in the Plan before taking any action related to the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>21.
</B><B>E<SMALL>LECTRONIC</SMALL> D<SMALL>ELIVERY</SMALL> <SMALL>AND</SMALL> A<SMALL>CCEPTANCE</SMALL></B><SMALL></SMALL>. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan
by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an <FONT STYLE="white-space:nowrap">on-line</FONT> or electronic system established and maintained by the Company
or a third party designated by the Company and that such online or electronic participation shall have the same force and effect as documentation executed in written form. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I-5. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>For U.S. Participants</I> </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>22. </B><B>M<SMALL>ISCELLANEOUS</SMALL></B><SMALL></SMALL>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a) </B>The rights and obligations of the Company under your option will be transferable to any one or more persons or entities, and all
covenants and agreements hereunder will inure to the benefit of, and be enforceable by the Company&#146;s successors and assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)
</B>You agree upon request to execute any further documents or instruments necessary or desirable in the sole determination of the Company to carry out the purposes or intent of your option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c) </B>You acknowledge and agree that you have reviewed your option in its entirety, have had an opportunity to obtain the advice of
counsel prior to executing and accepting your option, and fully understand all provisions of your option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d) </B>This Stock Option
Agreement will be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e) </B>All obligations of the Company under the Plan and this Stock Option Agreement will be binding on any successor to the Company,
whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I-6. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>For U.S. Participants</I> </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>TTACHMENT</SMALL> II </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2023 I<SMALL>NDUCEMENT</SMALL> P<SMALL>LAN</SMALL> </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>For U.S. Participants</I> </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ATTACHMENT III </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N<SMALL>OTICE</SMALL> <SMALL>OF</SMALL> E<SMALL>XERCISE</SMALL> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NeuroPace, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">455 N Bernardo Avenue</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Mountain View, CA 94043</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date of Exercise: _______________</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This constitutes notice to NeuroPace, Inc. (the &#147;<B><I>Company</I></B>&#148;) under my stock option that
I elect to purchase the below number of shares of Common Stock of the Company (the &#147;<B><I>Shares</I></B>&#148;) for the exercise price set forth below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Type of option (check one):</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Nonstatutory</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Stock option dated:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of Shares as</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">to which option is</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">exercised:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certificates to be</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">issued in name of:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Total exercise price:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$&nbsp;&nbsp;________________</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Cash payment delivered herewith:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$&nbsp;&nbsp;________________</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Regulation T Program (cashless exercise<SUP STYLE="font-size:75%; vertical-align:top">1</SUP>):</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$&nbsp;&nbsp;________________</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By this exercise, I agree (i)&nbsp;to provide such additional documents as you may require pursuant to the
terms of the NeuroPace, Inc. 2023 Inducement Plan, and (ii)&nbsp;to provide for the payment by me to you (in the manner designated by you) of your withholding obligation, if any, relating to the exercise of this option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I agree that, if required by the Company (or a representative of the underwriters) in connection with the first underwritten registration of
the offering of any securities of the Company under the Securities Act, I will not sell, dispose of, transfer, make any short sale of, grant any option for the purchase of, or enter into any hedging or similar transaction with the same economic
effect as a sale with respect to any shares of Common Stock or other securities of the Company for a period of one hundred eighty (180)&nbsp;days following the effective date of a registration statement of the Company filed under the Securities Act
(or such longer period as the underwriters or the Company will request to facilitate compliance with FINRA Rule 2241 or any successor or similar rule or regulation). I further agree to execute and deliver such other agreements as may be reasonably
requested by the Company or the underwriters that are consistent with the foregoing or that are necessary to give further effect thereto. In order to enforce the foregoing covenant, the Company may impose
<FONT STYLE="white-space:nowrap">stop-transfer</FONT> instructions with respect to securities subject to the foregoing restrictions until the end of such period. </P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares must meet the public trading requirements set forth in the Stock Option Agreement.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">III-1. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>For U.S. Participants</I> </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Very truly yours,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Signature</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Print Name</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Address of Record:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">III-2. </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>npce-20230718.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 7/19/2023 11:12:35 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:npce="http://neuropace.com/20230718"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://neuropace.com/20230718"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="npce-20230718_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="npce-20230718_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>npce-20230718_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 7/19/2023 11:12:35 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>npce-20230718_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 7/19/2023 11:12:35 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="npce-20230718.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139806946282512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 18, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NeuroPace Inc<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001528287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 18,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-3550230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">455 N. Bernardo Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Mountain View<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">237-2700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NPCE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d451420d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="npce-20230718.xsd" xlink:type="simple"/>
    <context id="duration_2023-07-18_to_2023-07-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001528287</identifier>
        </entity>
        <period>
            <startDate>2023-07-18</startDate>
            <endDate>2023-07-18</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-07-18_to_2023-07-18"
      id="Hidden_dei_EntityRegistrantName">NeuroPace Inc</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2023-07-18_to_2023-07-18">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-07-18_to_2023-07-18"
      id="Hidden_dei_EntityCentralIndexKey">0001528287</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-07-18_to_2023-07-18">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-07-18_to_2023-07-18">2023-07-18</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-07-18_to_2023-07-18">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-07-18_to_2023-07-18">001-40337</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-07-18_to_2023-07-18">22-3550230</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-07-18_to_2023-07-18">455 N. Bernardo Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-07-18_to_2023-07-18">Mountain View</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-07-18_to_2023-07-18">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-07-18_to_2023-07-18">94043</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-07-18_to_2023-07-18">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-07-18_to_2023-07-18">237-2700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-07-18_to_2023-07-18">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-07-18_to_2023-07-18">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-07-18_to_2023-07-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-07-18_to_2023-07-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-07-18_to_2023-07-18">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-07-18_to_2023-07-18">NPCE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-07-18_to_2023-07-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-07-18_to_2023-07-18">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2023-07-18_to_2023-07-18">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( !V \U8'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  =@/-6<-NY#N\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M:L,P#(=?9?B>R$G8/Y/ZLM+3!H,5-G8SMMJ:Q8ZQ-9*^_9RL31G; ^QHZ>=/
MGT"M#D+W$9]C'S"2Q70UNLXGH<.*'8B" $CZ@$ZE,B=\;N[ZZ!3E9]Q#4/I#
M[1%JSF_ (2FC2,$$+,)"9+(U6NB(BOIXPAN]X,-G[&:8T8 =.O24H"HK8'*:
M&(YCU\(%,,$(HTO?!30+<:[^B9T[P$[),=DE-0Q#.31S+N]0P=O3X\N\;F%]
M(N4UYE_)"CH&7+'SY-?F8;W=,%GSNBGX;5'=;VLN.!?7=^^3ZP^_B[#KC=W9
M?VQ\%I0M_+H+^0502P,$%     @ '8#S5IE<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M"  =@/-60+C9<F4$   G$0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V887/B-A"&_XK&[73:F22V!022 C.$)-?T+AP-:6^FG7X0M@#-V9(KR4#^
M?5<VL6G/K/D"EO&^?K0KO9(8[I3^:C:<6[)/$VE&WL;:[-;W3;3A*3-7*N,2
M?EDIG3(+3;WV3:8YBXN@-/%I$%S[*1/2&P^+>W,]'JK<)D+RN28F3U.FW^YX
MHG8C+_3>;[R(]<:Z&_YXF+$U7W#[>S;7T/(KE5BD7!JA)-%\-?(FX>T=[;F
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MF?%<JSE00OHCA*M;<751O0E4-2XJ^YBP=1,/'K]BB>$(1Z_BZ)V3GRF0:)9
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MU^09!K@6+&GDP55:>6KC#W'7GFM>I(?##"O7;]CFP ;Q\VIUHGZX7AL9K5<
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M7>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    "  =@/-6)!Z;HJT
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M2P$"% ,4    "  =@/-6!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( !V \U9PV[D.[P   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M !V \U:97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ '8#S5D"XV7)E!   )Q$  !@
M     ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M !V \U:?H!OPL0(  .(,   -              "  :D,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ '8#S5I>*NQS     $P(   L              ( !
MA0\  %]R96QS+RYR96QS4$L! A0#%     @ '8#S5APX9>H_ 0  / (   \
M             ( !;A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( !V
M\U8D'INBK0   /@!   :              "  =H1  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( !V \U9ED'F2&0$  ,\#   3
M          "  ;\2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(   D4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d451420d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d451420d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="d451420d8k.htm">d451420d8k.htm</File>
    <File>d451420dex101.htm</File>
    <File>npce-20230718.xsd</File>
    <File>npce-20230718_lab.xml</File>
    <File>npce-20230718_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d451420d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d451420d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "npce-20230718_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "npce-20230718_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "npce-20230718.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "npce",
   "nsuri": "http://neuropace.com/20230718",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d451420d8k.htm",
      "contextRef": "duration_2023-07-18_to_2023-07-18",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d451420d8k.htm",
      "contextRef": "duration_2023-07-18_to_2023-07-18",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://neuropace.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-23-189608-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-189608-xbrl.zip
M4$L#!!0    ( !V \U;"F:VM>A$  )AO   .    9#0U,30R,&0X:RYH=&WM
M'6MSVDCR^U;M?YAB;Z]PE7E(0&QCARL'DRR["79A[]W6?=D:I,',1FB4&<G
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M,%Y?WJX!'H==UH=>D=3T^!,YNU ^*5BG?X8B\Y1K=% ";D "2-MW+DHS "T
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MB J8@^&-2[A/>*@(: (0)CFOIUXY=06G/@4QF$6B/8\1AWD>NCDZJUK.Z>>
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M^4U8JF>>%.K%R+X1$)5Y_^7!8R*\QEFU7%V2@_PVO.<-^,O'&,*<5B"!$WE
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MU^7-[#LFYCWZ=.LH7X0OM#<F73V'9K(=D':\&]L,J<LT>.BJZG=T8,F!T/A
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M\7Z*%7@Z/,_<Z7)+"'0%,K7!<I"MTYQ76ZY@L4Z*I+[ !O;48R;*91!((_I
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M^Q"[>E!:-P5\2VY@AT!%T$[4T9[_%0TIT5>6Y#&J=]TX3.%^[!"C>B3X%P7
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MR1JG[Z9I3JLI3$>8.0P-&CVNG@SU=.Y]N=/YVIS.9-7A[/>.BAJED>,='(X
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M$8P/(J'P?2/2ZDBRPMLP!DM>81@:B PG-(DRF.9"35@XLI\>92Q-78!R6HQ
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MM3QH RVA7QA,#^!RXPP]40-,3I%OD#!O?"B]0$5^6:;J8ZRCX#@I4V"TG.S
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M^G@)P\WT4EE3-ME*E(\JI\-6?(3NT2A1@$_'!HI4CV#&65L[@L)#J'3BIG
M<21#TRDUH*;29#@!MCV$DY>5);N[R)!/Y]0TI$7G7NL[DO_3W N7W%H6DS:D
MDU"H46H<HO[F+)L<JA+3(;RRI. LEOK?<44VE%0,:@J-5,03Y_\S\P#U9<F)
M9Q\&SM1)MH'T;J%5$T:"-XAKE;99;HZZ\ TPJ;@332/("+'KVM!N'4Y%#'M#
M(MTWBTVI0:^!7*;\2@^+.E!-=@UH9U+^!XT]MR('(S]T&EO@HY 1!9V=.^?>
MJ!;'.5&$BGR#FAN!K\":SDK[I1"]MTJR[]![N_OPA_OV:W2 A<-^X'$]@/K%
MC2C532%?0"RQB[!O7.1:Z/<"GN>3^+S0EOY"C%-79FQ#,^>/<2)BOT73<XIO
M0#-#4^[1;4(ANTAMH5IE9=Z*"T.'B[JO!UH0-<';&X_!1B=HK9DX=>?ID$SG
M&7HX\&R:> X[QP-<BM0C(!6EX$?P<XXW1J>S\6D\U0[B*X2P-GLV#N&5<NZH
M@?\M,+[/S;:XL"/\:<AX5R&JG520,M=&?1,D=1JU/J\O??U2OT?\R=^I(8#4
M%$2$=>WQ/!53LG,8&D%H#((KXU<L(S/?R#_0A$3RN@(&VC712MM:(8> HYK\
M8U'FU8A3(@G9O=D&7D2(H: *6\T!*4[$P6;005Q]VA"K&]F;&9O<#;1)XSM#
M@]83A-K2C9Y>'7X;V\P8827!X*TX#!KP!'4RTI:@AU+:Y5WF\P"-2,?5HE=M
MQH;*M@VL$]XA(29*4>1R5JO#MT+,"6Y,OS>!FS@##U\T="]R.JL)UL-=!KE'
MJ[(;[D@E3$<KV B>6]DCSBAK)RF:6 -W@O'D^DZV#MX_ZF)L64)T/'1WW.^7
MI)0/W4(AT2_$R 9;<;R83![0G-T3I)%AX#ZZ3KZE3X0+Q?2*P>E)AGHATAZW
MI]MNP0'T]!FQ_&9K>IO:<BF'A[EI>ZX-E6 I^,441H=S1<6]FA>BU>-Z:]:
M#]A0LH<J?Y*PS!V^XR97)@6PH:QIIIC:6S0ES023IF::1=:!C^AW)J(\42L5
M10-NF.39(G$Y]#:[GIBP= 5T$Q[(+M$W/0X3&(N2#.2L1(L>VE1)(UM8T9O8
M>>^^M=34XBV,NW1'JQL+6;>XA1Z:#9E3XVU8 5Q 6K4]T.Q+Y ,M$4.N?>?0
M3\2H^1CZTO? +TO>"'P,_VB)0L"[ R 0 ]Z',3$LM=?^FZD;GF\YA\&5".+
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M&&?O99_1CU?91EMC*5OL,-=](1GW FF[J3+^-]@2^(1T$N)@9H9>F=HQ1,T
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MGQD"G:+H9"T_5,P60>]"D2IL!N]E%UM>V=:V;(6@7A96A3@3$:]9W& Q?_P
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MTO,612?K$OW>,FWBP7/M\7=BVVB>KFRC29CD5VD^T30=[=FI#FQ2GL;4D5&
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M:2D[0DNF\C068ERIEF=NK9<\!E_(K@B*#LXIU7YR;G2"L\W'>38RV4[G-ZX
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M31(O"+5*O*;J$3.(*Z+,5.P E:)S^BR^90HK44E9 M"],I0\JWBP+O/&)=<
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MP:F5L$'/(['^2G:*L_;\_[=W;3UM(U'X'2G_P>KN2B %2BATN[1%"B%M(]&
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M& C(_H77<S%2CL4H:(4$=E CPBC[C;K9>1R-V*L'C+9$8/M0T@7W@2W-)NK
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M^0,29@&O4L<T\L&[ISSVWW);V%]0J>^_>. %'ONDQ]]SIFNV7*78_O$=58G
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M??/\^.SDL_KR0_OCZ='_4$L#!!0    ( !V \U8-,E8W/0,  $0+   1
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MW!_!<# 8,6H'1TG&'D0*]6,'PHMGU!E])QN0ZU$ I./QF 7I&J7"W8V@M7[
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MP;6@6L>T9L."_C.\$*(_UIO7<H(/XEG@%X>_!.PM=FS0/X:1(?]4LB7@31I
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M,C!D.&LN:'1M4$L! A0#%     @ '8#S5LUVV.=8A   8\ " !$
M     ( !IA$  &0T-3$T,C!D97@Q,#$N:'1M4$L! A0#%     @ '8#S5@TR
M5C<] P  1 L  !$              ( !+98  &YP8V4M,C R,S W,3@N>'-D
M4$L! A0#%     @ '8#S5E#QM,^1!@  JD8  !4              ( !F9D
M &YP8V4M,C R,S W,3A?;&%B+GAM;%!+ 0(4 Q0    ( !V \U;@%! %TP0
M #<L   5              "  5V@  !N<&-E+3(P,C,P-S$X7W!R92YX;6Q0
52P4&      4 !0!  0  8Z4

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
